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ABSTRACT
DESIGN, SYNTHESIS AND CHARACTERIZATION OF ARTIFICIAL
EXTRACELLULAR MATRIX PROTEINS FOR
TISSUE ENGINEERING
SEPTEMBER 1997
ALYSSA PANITCH, B.A • / SMITH COLLEGE
B.S UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor David A. Tirrell
Artificial extracellular matrix proteins were
synthesized using recombinant DNA technology. These
proteins were meant to mimic the internal elastic lamina of
the tunica intima of muscular arteries for use in the design
of small diameter (<6 mm) vascular prostheses. These
proteins are composed of two blocks, an elastin-like block
made up of repeats of the pentapeptide (VPGIG) and a cell
binding segment which is composed of the CSS region of
fibronectin. Proteins of the following sequence were
designed, synthesized and characterized: (CS5 (VPGIG) 40) 3 and
(CSS (VPGIG) 20) 5* Successful synthesis and purification were
confirmed by NMR spectroscopy and amino acid analysis.
These artificial extracellular matrix proteins were
designed with both controlled structural integrity and
endothelial cell binding ability. The presence of a lower
critical solution temperature (LCST) for both proteins
VI
suggests that the properties of the elastin like blocks were
maintained. The endothelial cell binding ability of the CS5
region of fibronectin was also retained, as demonstrated
through human umbilical vein endothelial cell (HUVEC)
adhesion and spreading on the proteins, as well as through
inhibition of this adhesion through preincubation of the
HUVECs with soluble GREDVDY peptide which is known to
inhibit a43i integrin binding to CSS. Equivalent numbers of
HUVECs adhered to (CSS (VPGIG) 20) 5 and to fibronectin,
although the number of cells well spread on the former was
only approximately 5S% of the number of those well spread on
fibronectin.
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CHAPTER 1
INTRODUCTION
The field of tissue engineering draws upon multiple
disciplines to achieve its goal of the design of new
materials for tissue regeneration. It is a rapidly
expanding field where knowledge about cell-cell and cell-
material interactions, as well as about cell-protein, cell-
chemical and cell-mechanical interactions are drawn upon to
design materials that will optimize cell growth and
differentiation and tissue regeneration both in vitro and in
vivo. Extensive research is being conducted on materials
for growth of new skin, liver, bone, cartilage and arteries,
among other tissues. ^"^ These materials are often scaffolds
that support cells and allow them to attach, proliferate,
differentiate, and secrete their own scaffolding or
extracellular matrix. Each organ has its own
characteristics important in the successful design of
synthetic materials for cell scaffolding; the composition of
the extracellular matrix differs from tissue to tissue.
While cartilage supports the weight of the body, blood
vessels provide the transport network for nutrients and
waste; in view of these differing functions, it is not
surprising that cartilage is composed of more connective
tissue, a collagen rich matrix, while muscular arteries are
composed of more muscular tissue. Materials for
1
regeneration of any organ must provide the proper signals
for the defined organ.
1.1 Vascular Grafts
Vascular grafts, or artificial blood conduits, are used
to replace damaged or diseased vessels. New materials for
small diameter vascular grafts are needed. The current
gold standard for bypass surgery, autologous saphenous vein,
has a 30% failure rate due to stenosis within five years.
^
Expanded polytetrafluoroethylene (PTFE) and polyethylene
terephthalate (PET) are also available for vascular graft
implantation; however, the patency rate of these materials
is lower than that of saphenous vein^. Desirable materials
would provide a vessel viable for the life of the patient.
Novel artificial extracellular matrix proteins can
readily be designed and synthesized utilizing recombinant
DNA technology. These proteins may contain isolated
biological signals or a combination of signals. More
specifically, cell adhesion domains such as the peptide Arg-
Gly-Asp (ROD) can be designed into the backbone of the
protein.^ It is equally possible to synthesize materials
which contain heparin binding domains, collagen binding
domains, or protease degradation sites. Mechanical
properties of the protein can also be controlled; one way to
accomplish this is by designing an elastomeric-type protein
endowed with mechanical properties similar to those of
native elastin.''"' Elastin is an extracellular matrix
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protein which composes the bulk of elastic fibers; these
fibers are found, among other places, in the intima of
muscular arteries. ^° We have synthesized an elastomeric
protein containing (i) repeats of (VPGIG) (the single letter
amino acid code is used in this and all subsequent protein
sequences), and (ii) the CSS domain of fibronectin, an
integrin binding domain containing the REDV sequence.
This protein binds human umbilical vein endothelial cells
(HUVECs) and is expected to exhibit mechanical properties
similar to those seen in chemically synthesized repetitive
polymers of (VPGVG)
, a pentapeptide repeat occurring up to
11 times consecutively in native elastin.^^
In the case of vascular grafts it is likely that an
elastic material will be better than a rigid material, as
arteries are quite elastic. A material must be sufficiently
viscoelastic to maintain flow during diastole^ and must have
sufficient structural integrity so that the new artery does
not burst during systole. Materials must be porous enough
(-100 /im) to allow diffusion of metabolites and migration of
cells (such as smooth muscle cells to form a media)
,
yet
they must remain mechanically sound. The materials must be
biocompatible if they are to be implanted in the body; a
material that elicits a severe immune response will likely
be rejected while those that elicit an inflammatory response
may be "walled off" by fibrous tissue deposition. In
addition, these materials must interact favorably with the
cells of the vasculature including endothelial cells, smooth
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muscle cells and platelets. Materials should not promote
thrombosis or intimal hyperplasia. To date, native tissue
is optimal for its function. This knowledge must be
utilized in the design of new materials. The ideal
synthetic scaffold will support cell growth and
differentiation as well as maintain mechanical integrity
until the seeded or ingrowing cells secrete their own
extracellular matrix. Finally, the synthetic material
should degrade, leaving in its stead a native tissue. ^'^
Selecting a suitable material for vascular graft
fabrication is quite complex. Vascular grafts are
immediately exposed to the blood, allowing for the rapid
deposition of blood-borne proteins. These proteins are
deposited on the graft surface. Proteins present in the
bloodstream at the highest concentrations are initially
deposited in the highest concentrations. Over time
equilibrium prevails; those proteins which adhere most
strongly to the vascular graft material will be present at
higher concentration than seen initially.
The adhesion of blood-borne proteins to foreign
material, in particular f ibrinogen, often promotes
platelet adhesion. This may trigger a cascade of events^^
leading to thrombosis, atherosclerosis and ultimately to
graft failure. Exposure to the blood stream also invokes an
immune or foreign body response. This response has been
extensively studied and is found to be dependent on graft
material. In general, bioresorbable materials^^ elicit a
greater foreign body response (which terminates after
complete resorption) than nonresorbable materials, but the
response to the nonresorbable material continues
indefinitely. One approach to the problem of protein
adhesion is the modification of surfaces to create
nonadhesive interfaces. The modification of polyethylene
terephthalate (PET) surfaces with polyethylene oxide
(PEO) (which increases both the hydrophilicity and mobility
of the surface by motion of the PEO) has been used to make
surfaces less adhesive to proteins and cells/® hence, less
thrombogenic. PTFE has been modified by plasma
polymerization of tetrafluoroethylene to PTFE films followed
by adhesion of albumin. Plasma polymerized PTFE shows an
increased affinity for albumin. Surfaces pretreated with
albumin are less adhesive toward platelets. Conversely,
plasma polymerized PTFE in the presence of oxygen has been
shown to increase the retention of fibronectin and laminin,
hence increasing the adhesion of HUVECs.^°
Healthy vasculature is lined with a monolayer of
endothelial cells which serves many functions including
creating a naturally nonthrombogenic surface. It may be
possible to achieve a monolayer of endothelial cells lining
the luminal surface of a vascular graft via the growth of
capillaries through the wall of the implant and the
subsequent migration of endothelial cells to the graft
surface. The use of highly porous (60/xm internodal
distance) ePTFE has been shown to allow capillary ingrowth
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through the walls of the vessel and migration of capillary
endothelial cells onto the graft to form a continuous layer
of endothelial cells in both primates^^ and canines.
However, in humans the only endothelial cell migration in
currently available vascular grafts occurs from the ends of
the graft and proceeds for only 8-lOmm before stopping,
leaving the center of the graft devoid of endothelial
cells.
Another approach to designing patent vascular grafts is
to preseed the graft with endothelial cells." This is done
to form a nonthrombogenic surface which appears, on the
macroscopic level, to be similar to the native vessel.
Preseeding of vascular material has not yet been shown to be
an effective method for increasing the patency rate in
humans. However, preliminary data from the labs of both
Peter Zilla^^ and Stewart Williams (personal communication)
suggest patency rates of autologously preseeded PTFE grafts
are equal to autologous saphenous vein at 5 years post-
implantation .
An alternative method for seeding of endothelial cells
is the use of short peptide sequences for cell binding.
RGDS and related peptides have been shown to bind a variety
of cell types through integrin receptors on the cell
surface. Grafting of RGD sequences to PTFE surfaces has
shown an enhancement of endothelial cell binding to the
graft material in vitro both in the absence and in the
presence of flow.^^ Massia et al . covalently bound both
6
RGDS and REDV to glycophase glass, glass which has been
treated with (3-glycidoxypropyl) trimethoxysilane followed by
hydrolysis of the oxirane moieties to form diols, and
demonstrated that cells would adhere to the peptide-modif ied
surface of the glass. They also found that endothelial
cells, but not smooth muscle cells, platelets, or
fibroblasts would adhere to the REDV modified glass
surface. This demonstrates the ability to adhere
selectively certain cell types to surfaces through these
peptides. In addition, it has been shown that cell adhesion
and proliferation are dependent on the density of adhesion
peptides. ^° The density of the peptides may be used to
control the action of the adherent target cells. Although
these peptides may be readily grafted to the surface of
existing materials, making these materials more adherent
toward cells, they do not alter the overall properties of
the materials. Grafting peptides to PTFE and PET does not
improve the mechanical properties of these materials, nor
does it promote degradation.
A material which supports a monolayer of endothelial
cells while inducing them to produce their own matrix,
allows the endothelium to remain in an inactivated state,
and is conducive to the development of an intima and a media
comprises an optimal vascular graft material.
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1.2 Material Design Through Genetic Engineering
Genetic engineering is a powerful technique that, when
combined with ideas from polymer science, allows the
researcher to design materials with precise molecular
sequences and controlled architecture. We and others have
previously reported the biosynthesis of highly repetitive,
monodisperse, silk-like proteins, including derivatives
containing non-proteinogenic amino acids or elastomeric
domains
.
^^'^^ The successful synthesis of elastin-like
proteins by this method has also been reported. ^'^ In
addition, we have described the successful synthesis of
poly (alanylglycine) in multigram quantities, and have
subsequently applied the described technique to produce
multigram quantities of a variety of recombinant proteins in
our laboratory. The ability to synthesize multigram
quantities of protein is critical for vascular graft design,
as reasonable quantities of material must be readily
available for mechanical testing and processing of
prosthetic devices.
Due to the ability to control precisely the amino acid
sequence of recombinant proteins, we felt it would be
possible to design an elastomeric protein containing
integrin binding domains that would bind endothelial cells
while remaining nonadhesive toward smooth muscle cells,
platelets and fibroblasts.^^ In addition to controlling the
sequence of the domains, we are able to dictate the density
of the domains, which has been shown to be important in cell
8
adhesion, spreading, focal adhesion contact formation/^ and
cell motility/^ This elastin-like protein could be used as
the innermost tunica of a vascular graft. Since this
material is protein, it is thought that it will eventually
be degraded by the body through natural processes which will
result in nontoxic units that can be utilized by the body or
cleared from the body through normal channels.
In the work reported herein, recombinant proteins were
designed based on the pentapeptide repeat (VPGIG) which is
known to form a beta turn structure and to have mechanical
properties similar to those of native elastin. ^^'''^
Periodically interspersed with the pentapeptide repeat is
the CSS region of fibronectin, which has been shown to bind
to the a43i integrin receptor , a receptor which is found
on HUVECs but has not been found on smooth muscle cells,
platelets or f ibroblasts.^^'^^''^^ Scheme 1 shows the sequence
of the CS5 region plus amino acids resulting from the
linking of the segments at the DNA level.
Scheme 1
.
CS5 = (LDGEEIQIGHIPREDVDYHLYPGVP)
OVP = insertion site for (VPGIG)
LD = amino acids resulting from DNA linking
The cimino acid sequences of the complete proteins are:
MG(CS5(VPGIG) JyLE
Where X, Y = 20, 5 or 40, 3
The entire CSS region of fibronectin was incorporated into
the protein because it was expected that conformation of the
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REDV peptide was important for HUVEC binding. Hubbell et
al. demonstrated that GREDVY peptide coupled to a surface
through the amino terminus was recognized by HUVECs as an
adhesion site, while the same peptide coupled through the
carboxyl terminus did not appear to be recognized by the
HUVECs as it did not promote adhesion/^ This was further
confirmed by Nicol et al . when short forms of the REDV
peptide were incorporated, through chemical synthesis, into
repeats of (VPGVG)^ and no HUVEC binding was observed
however, incorporation of short RGD peptides into proteins
composed of (VPGVG) repeats does promote endothelial cell
binding, indicating that the elastin backbone is compatible
with cellular adhesion/^ \
The recombinant proteins, (CSS (VPGIG) 40) 3 and
(CSS (VPGIG) 20) 5; serve two functions: the CSS region provides
the signals for cell adhesion while the (VPGIG) repeat
provides the desired mechanical properties. The
construction of the proteins was based on two DNA monomers
that encode the CSS region or the (VPGIG) repeats,
respectively. These monomers were interconnected through
cohesive ends to build the genes of interest, which were
cloned into an Escherichia coli expression host.
1.3 Tissue and Organ Complexity
These novel extracellular matrix proteins are meant to
serve as the internal elastic lamina of an artery. However,
as with other organs, the arteries are composed of more than
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one tissue. In most tissue engineering applications, it is
likely that more than one material will be necessary to
rebuild the tissue of interest. Different materials elicit
different responses from cells. Chondrocytes cultured on
type 1 collagen secrete large amounts of collagen, while the
same chondrocytes cultured on polyglycolic acid secrete
large quantities of proteoglycans.''^ Several signals may be
necessary to create the optimal environment for tissue
regeneration, while more than one material may be necessary
to achieve the desired mechanical properties or even the
desired structure.
Arteries are made up of three layers or tunicas. The
composition of each tunica is different, both in dominant
cell type and in extracellular matrix composition. The three
tunicas, as seen from the lumin outward, are the tunica
intima, the tunica media, and the tunica adventitia. The
muscular arteries are the vessels of interest for vascular
graft design, for it is these arteries that fail.^ The
tunica intima of muscular arteries is lined with a monolayer
of endothelial cells which lie on a basal lamina.
Immediately juxtaposed to the endothelium is an internal
elastic membrane. Elastic, artificial extracellular
matrix proteins such as those based on the (VPGIG) repeat
may be able to mimic this tunica. The tunica media of these
arteries consists largely of smooth muscle cells surrounded
by collagen. An artificial collagen which binds smooth
muscle cells may be able to mimic the tunica media. The
adventitia consists of both elastic and collagen fibrils and
fibroblasts.^^ It will be possible to blend the elastin
like proteins with collagen analogues to mimic both the
tunica media and the adventitia. Multilayered vascular
grafts can then be fabricated to produce vascular
prostheses.
1.4 High Cell Density Fermentation
In order to fabricate grafts it is necessary to produce
the graft materials in large quantities. We have found
through batch fermentation that it is possible to produce
10-100 mg/1 of recombinant protein. Considering the best
case where 100 mg/1 of protein was produced, a 10 1
fermentation is necessary to produce 1 g of recombinant
protein. This is not time or cost effective. Through a fed
batch fermentation process which is a modification of the
process by Riesenburg et al.^° we have been able to improve
protein yields so that we can recover approximately 1 g/1 of
recombinant protein.
1.5 Dissertation Plan
Chapter 2 describes the high cell density fermentation
procedure as well as the design, synthesis and
characterization of poly (alanylglycine) . Batch and fed
batch fermentations are compared and the recombinant protein
is evaluated by NMR spectroscopy, elemental analysis and
12
amino acid analysis, as well as Fourier transform infrared
spectroscopy and x-ray diffraction.
The recombinant artificial extracellular matrix
proteins are introduced in chapter 3. They are evaluated by
amino acid analysis and NMR spectroscopy. The ability of
HUVECs to adhere to the proteins and the number of cells
attached to protein surfaces are also discussed.
The morphology of HUVECs on the protein surfaces and on
glass is evaluated in chapter 4. LCST data of the proteins
is presented as well as the stability of films of the
proteins in aqueous solutions above the LCST.
The appendices contain more detailed information on DNA
manipulations and on protein characterization.
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CHAPTER 2
Poly (L-ALANYLGLYCINE)
: MULT IGRAM-SCALE BIOSYNTHESIS,
CRYSTALLIZATION, AND STRUCTURAL ANALYSIS
2 . 1 Abstract
The biosynthesis of poly (L-alanylglycine) (poly (AG))
was performed in high cell density cultures of recombinant
Escherichia coli
. The purity of the material was determined
by amino acid analysis, elemental analysis and ^H NMR
spectroscopy. Fed batch fermentation increased the yield of
recombinant protein from levels of tens of milligrams per
liter (typical of batch fermentation in rich media) to
hundreds of milligrams per liter. Poly (AG) was
recrystallized from dichloroacetic acid solutions in the
form of texture-oriented chain-folded lamellae with a
lamellar stacking periodicity of 3.2 nm. The crystal
structure within the lamellar core is similar in general,
but different in detail, to the antiparallel 3-sheet
structure previously reported for oriented films of poly (AG)
and fibers of Bombyx mori silk fibroin (silk II) . The
structure consists of polar antiparallel (ap) p-sheets, with
repetitive folding through y-turns every eighth amino acid
(including the fold), stacking with like surfaces together.
The wide angle x-ray diffraction signals index on an
orthorhombic unit cell with a (hydrogen bond direction) =
0.948 nm, Jb (sheet stacking direction) = 0.922 nm, and c
(chain direction) = 0.695 nm. The stacking distance (b-
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value) is increased by about 4% in comparison with the
previously reported structure of poly (AG)
,
owing, we
believe, to steric interaction at the lamellar fold
surfaces. Random shears of approximately ± a/ 4 and
alternating shears of +c/2 and -c/2 in the ac plane are
required to obtain a good fit between the calculated and
measured x-ray structure factors.
2 . 2 Introduction
Recombinant DNA technology is a powerful tool for
synthesis of novel proteins for pharmaceutical and
biomedical applications^^' as well as for research in
structural biology and protein folding. We and others have
previously reported^^'"'^^'^" the biosynthesis of highly
repetitive, monodisperse, silk-like proteins, including
derivatives containing non-proteinogenic amino acids^^ or
elastomeric domains. ^^'^^ We describe herein the preparation,
on a multigram scale, of two monodisperse variants of the
"parent" polymer in this family of materials, poly(L-
alanylglycine) (poly(AG)). These polymers can be
crystallized to form silk Il-like p-sheet structures, as
shown by Fourier transform infrared spectroscopy (FTIR)
,
small angle x-ray scattering (SAXS) and wide angle x-ray
scattering (WAXS)
.
Poly (AG) (as prepared by chemical synthesis) has been
studied previously . "'^^ Eraser et al. prepared poly (AG) by
polymerization of an L-alanylglycine p-nitrophenyl ester
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monomer, resulting in a degree of polymerization of about
40." Lotz and Keith used the pentachlorophenyl ester as
monomer and obtained molecular weights in the range of
15,000 to 20,000." Infrared and x-ray scattering data
indicated that such polymers form either the silk I
(crankshaft geometry) or the silk II (3-sheet geometry)
structures depending on sample preparation conditions."
We have reported previously the use of genetic
engineering to produce artificial proteins that adopt
predictable, chain-folded antiparallel (ap) p-sheet
structures in the solid state. ^^'"'^^ The chain-folded
lamellar architecture^^'" is a kinetic trap in the
crystallization of all linear polymers sufficiently flexible
to form hairpin-like folds, and it is known that protein
chains in the 3-conformation can make tight turns, with
either one or two amide groups (two or three amino acid Cq,-
atoms) in the fold. The egg-stalk silk protein of the
green-wing fly Chrysopa flava folds with a periodicity
corresponding to eight amino acids to form lamellae of
thickness « 3 nm,^^ and nylons 4" and 4,6*^^ crystallize with
amide units, rather than polymethylene segments, in the
turn. The biosynthesis of multigram quantities of poly (AG)
with known chain lengths well in excess of the expected fold
periodicity allowed us to search for chain-folding in
poly (AG), and to compare the folded-chain structure with
that previously reported by Eraser et al.^^'^^
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The yield of a recombinant protein in bacterial
fermentations is determined in part by the total number of
cells in the culture. Traditional batch reactors yield
approximately 1.5 g dry cell weight per liter. This low
ratio of biomass to culture volume leads to low efficiency
in terms of space, time, and cost. Alternatively, fed batch
processes yield significantly greater cell densities; values
up to approximately 100 g dry cell weight per liter have
been reported.
We describe in this chapter simple fed batch techniques
with the addition of oxygen that have increased the yield of
poly (AG) from tens of milligrams per liter (using batch
techniques) to hundreds of milligrams per liter. We also
discuss the structural analysis of poly (AG) by infrared and
x-ray diffraction methods.
2 . 3 Experimental Section
2.3.1 Materials
T4 DNA liqase, T4 polynucleotide kinase, calf
intestinal phosphatase, and all restriction enzymes were
purchased from New Enqland Biolabs. Ribonuclease A,
Deoxyribonuclease I, Orqanic Antifoam, Ampicillin and
chloramphenicol were purchased from Sigma Chemical Co.
Escherichia coli strains DH5aF* and HBlOl were purchased
from Bethesda Research Laboratories. Plasmid p937.51 was a
gift of Protein Polymer Technologies, Inc. The expression
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plasmid pET-3b and E. coli strain BL21 (DE3)pLyss'^^
obtained from Novagen.
2.3.2 General Methods
Bacterial growth in rich medium, DNA manipulations and
transformation conditions were performed as described in
Sambrook, Frisch and Maniatis.^^ Fourier transform infrared
spectra were obtained from KBr pellets on a Perkin Elmer
1600 series FTIR spectrophotometer. NMR spectra were run
on a Bruker AMX 500 MHZ spectrometer. Ultraviolet spectra
were obtained in distilled water on a Hitachi U2000
spectrophotometer in quartz cuvettes with a path length of 1
cm, while cell density measurements were done in plastic
cuvettes at X=600 nm. High cell density medium for
fermentations was adapted from Riesenberg et al.^° with the
addition of 100% O2 once an optical density (ODgoo) of 10 was
reached. A New Brunswick SOL mobile pilot plant (MPP-80)
was used for high cell density fermentation.
Centrifugation was performed using a Cepa Z41 continuous
centrifuge. Amino acid analyses were obtained from an
Applied Biosystems 420/130A derivatizer-analyzer following
hydrolysis and derivatization with phenylisothiocyanate;
data were analyzed with the Applied Biosystems 920A data
module.
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2.3.3 Preparation of Synthetic DNA
Oligonucleotides (1) were synthesized on a 1 ^i^nol scale
on a Biosearch Model 8700 DNA synthesizer using
phosphoramidite chemistry
. Crude oligonucleotides were
purified by denaturing polyacrylamide gel electrophoresis
and eluted using the "crush and soak" method.^'' Purified
oligonucleotides were annealed at 80 °C and allowed to cool
to room temperature over several hours. The annealed duplex
(1) was phosphorylated with T4 polynucleotide kinase,
ethanol precipitated and dried in vacuo.
stop Gly Ala Gly Ala Gly Ala Gly Ala Gly
AAT TOG TAA GGT GCC GGT GCG GGT GCA GGT GCG GGT GCC GGC (1)
ATT CCA CGG CCA CGC CCA GGT CCA CGC CCA CGG CCG AGII II
Eco RI Ban I Ban I Bam HI
2 •3.4 Cloning and Amplification of Synthetic DNA
The purified synthetic duplex was ligated into Eco
RI/Bam HI digested pUC18^^ and used to transform E. coli
strain DH5aF'. Cells were grown at 37 °C overnight on 2xYT
solid medium containing 200 /ig/ml ampicillin, 25 jitg/ml 3-
isopropylthiogalactoside (IPTG) and 40 /xg/ml of the
chromogenic substrate 5-bromo-4-chloro-3-indolyl-3-D-
galactopyranoside (X-Gal) for blue-white screening. Plasmid
DNA from white transformants was sequenced using Sequenase
2.0 (Amersham Life Sciences) to verify the identity of the
insert. After isolation of the recombinant plasmid from a 1
liter 2XYT culture, the DNA was digested with Ban I and the
fragments were separated by nondenaturing polyacrylamide gel
electrophoresis. The DNA monomer was eluted from the
polyacrylamide slice using the "crush and soak" method."
2.3.5 Polymerization of the DNA Monomer and Cloning of DNA
Multimers
Purified monomeric DNA was self-ligated with T4 DNA
ligase to form a population of multimers. Multimers were
resolved by electrophoresis and ligated into Ban I digested,
dephosphorylated p937.51, a small, high copy number cloning
vector that carries an origin of replication from pBR322 and
a gene encoding chloramphenicol acetyltransferase . ^° The
recombinant plasmids were used to transform E. coli strain
HBIOI. Transformants were screened by restriction enzyme
digest analysis and clones encoding 16 and 60 repeats of the
monomer were selected. The recombinant plasmids were
designated p937 . 51- (AG) e-, or p937 . 51- (AG) 240 respectively.
2.3.6 Construction of Bacterial Expression Vector
Recombinant p937 . 51- (AG) or p937 . 51- (AG) ^ was
digested with Bam HI to release the multimer. The fragments
were separated by 1% low melting point agarose gel
electrophoresis and recovered by extraction with phenol and
with phenol/chloroform, and finally by ethanol
precipitation. The recovered DNA was ligated into Bam HI
digested, dephosphorylated pET-3b and used to transform
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E. coli strain HBlOl. Transformants were screened for the
presence and orientation of each multimer by Ava I
digestion. Recombinant plasmids, designated pET3b- (AG)
and pET3b-(AG)64 respectively, containing inserts in the
correct orientation were used to transform the expression
host, E. coli strain BL21 (DE3 ) pLysS
.
2.3.7 Protein Expression, Batch Phase, Rich Medium
Single colonies of BL21 (DE3) pLysS containing
recombinant pET3b- (AG) 240 or pET3b-(AG)e4 were used to
inoculate 5 ml of LB medium containing chloramphenicol (34
Hq/ml) and ampicillin (200 /xg/ml) . The cultures were grown
to saturation and used to inoculate 7 50 ml volumes of LB
medium containing chloramphenicol (34 jug/ml) and ampicillin
(2 00 /Lig/ml) . The cultures were grown to ODgoo = 1 at 37 C
and protein expression was induced by the addition of IPTG
to a final concentration of 0.4 mM. Cells were harvested
after 2 hours by centrifugation (2,520 x g, 15 min at 4 °C)
.
The cell pellets were resuspended in 10 mL of water and
stored at -20 "C.
2.3.8 Protein Purification
Frozen cells were thawed and phenylmethyl sulfonyl
fluoride (PMSF) (1 mM) , MgCl2 (5 mM) , RNAse (20 nq/ml) and
DNAse (20 ^iq/ml) were added. The solutions were incubated
at 37 °C for 3 0 min and the insoluble portion was recovered
by centrifugation (10,000 x g, 4 °C, 15 min). The pellets
were resuspended in 10 ml TENT solution (50 mM Tris-Cl (pH
8.0), 10 mM EDTA, 100 mM NaCl, 0.5-0.7% Triton X-100) and
incubated with shaking at room temperature for 3 0 min. The
insoluble portion was recovered by centrifugation
(10,000 X g, 4 C) for 15 minutes. The pellets were
resuspended in 10 ml of TENS (50 mM Tris-Cl (pH 8.0), 10 mM
EDTA, 100 mM NaCl, 0.5% sodium dodecylsulfate (SDS) ) and
incubated at room temperature with shaking for 60 min. The
insoluble portion was recovered by centrifugation
(10,000 X g, 4 "C, 15 min) and the TENS treatment was
repeated. The resulting pellet was resuspended in TEN plus
porcine pancreatic lipase (20 fig/mh) and incubated at 37 "C
for 3 0 minutes. The insoluble portion was recovered by
centrifugation (10,000 x g, 4 C, 15 min). The pellet was
then washed sequentially with 10 mL TENT, 10 mL water, 10 mL
chloroform: methanol : acetone 40:30:30, 10 mL of acetone,
10 mL water and 10 mL water. The insoluble portion was
recovered by centrifugation (10,000 x g, 4 °C, 15 min) after
each wash. The recovered fusion protein was then dried and
weighed.
2.3.9 Cleavage of Fusion Protein
Cyanogen bromide cleavage of the fusion proteins was
accomplished by the method of Smith. ''^ Approximately 35 mg
of fusion protein was dissolved in 5.5 mL of 98% formic acid
and diluted to 70% formic acid with distilled water. The
solution was deoxygenated with nitrogen and 50 mg of CNBr
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crystals was added. The solution was stirred at room
temperature for 24 hr and the solvent was removed by rotary
evaporation. The residue was washed with distilled water
several times and the insoluble portion was recovered by
centrifugation and dried by lyophilization.
2.3.10 High Cell Density Fermentation and Protein Expression
A 5 ml volume of 2xYT medium containing chloramphenicol
(34 Mg/ml) and ampicillin (200 /xg/ml) was inoculated with a
single colony of BL21 (DE3) pLysS pET-3b(AG) 240- The culture
was incubated in a rotary shaker at 37°C until visible
turbidity was reached (approximately 6 hrs)
, and then used
to inoculate 100 mL of 2xYT medium containing
chloramphenicol (34 /xg/ml) and ampicillin (200 /ig/ml) . This
was grown to visual turbidity at 37 °C, and then used to
inoculate 2 liters of 2xYT medium containing chloramphenicol
(34 /Ltg/ml) and ampicillin (200 /itg/ml) . The culture was
grown to saturation overnight and the cells were harvested
by centrifugation at 4,000 rpm for 10 min. The resulting
pellet was used to inoculate 35 liters of the minimal
medium^° specified in Table 2.1. ampicillin and
chloramphenicol were added to final concentrations of 200
/Lig/mL and 34 /Ltg/mL respectively. Ammonium hydroxide (25%)
was used as the base (which was fed through the base pump of
the pH controller) , both to control pH and to provide a
nitrogen source. The culture was grown in an 80 liter New
Brunswick fermentor until the glucose was depleted as
determined by a rise in pH above the set point, pH 6,8. At
this time a glucose feed (50% w/v glucose/water) was
established. Glucose was fed through the acid pump of the
pH controller; pH was maintained at 6.8.^^ Pure O2 was used
to ensure aerobic conditions when air was insufficient to
maintain the dissolved oxygen concentration above 20%.
Induction was achieved by the addition of 1.0 mM IPTG when
the ODeoo reached 25-30. Cultures were grown for 4 hr prior
to harvesting by centrifugation with a Cepa Z41 continuous
centrifuge. Cells were weighed and resuspended in 4 mL of
water per gram of cells (wet weight) . Protein purification
was performed as described above.
2.3.11 Infrared Spectroscopy
Poly (AG) comprising 64 dyads ((AG) 64) was prepared for
crystallization by dissolving 30 mg of protein in 1 itiL of
98% formic acid. The solution was diluted to 70% formic
acid by addition of distilled water, and stirred until a gel
formed (about 10 hr) . The gel was washed with methanol,
dried and crushed to form a KBr pellet for infrared
analysis.
2.3.12 X-ray Diffraction
Poly (AG), in the form of a white powder, was
continuously added to a mixture of dichloroacetic acid and
10% aqueous lithium hydroxide at 60°C and stirred until a
gel formed. The gel was compressed between two filters at
50°C until dry (approximately 4 h) . X-ray diffraction
photographs from these compressed crystalline mats were
obtained using a Statton-type x-ray camera, evacuated to
backing pump pressure to reduce air scatter. The nickel-
filtered CuKa sealed beam source was collimated with a
system of 200 /xm pinholes. The diffraction photographs were
recorded on x-ray film with specimen-to-film distances of
50-100 mm. X-ray diffraction photographs of the mats were
obtained with the x-ray beam directed either parallel or
perpendicular to the surface of the mat.
2.3.13 Computer Modeling and Simulated X-ray Diffraction
Patterns
Molecular modeling was performed on a Silicon Graphics
Iris 4D20 workstation using the following software packages:
Discover 2.9 (Biosym Technologies) and Cerius 2, Release 1.6
(Molecular Simulations, Inc.). The simulated x-ray
diffraction patterns were created on a Silicon Graphics
Indigo R4000 using the Diffraction 1 module of the Cerius 2,
Release 1.6, program. The appropriate Lorentz and
polarization correction factors are incorporated in the
displayed intensities. The degree of arcing and the
temperature factor were chosen to match the observed x-ray
diffraction photographs.
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2.4 Results and Discussion
2.4.1 Gene Construction
The strategy used in our laboratory to prepare
artificial proteins has been described previously
. In
this work, DNAs encoding two chain-length variants of
poly (AG) were ligated into the Bam HI site of the expression
plasmid pET-3b. The resulting recombinant plasmids encode
either 16 or 60 repeats of the alanylglycine tetramer,
flanked by N- and C- terminal extensions of 23 and 33 amino
acids respectively (2) . These terminal regions are derived
from the transfer and expression vectors and can be removed
by CNBr cleavage at flanking methionine residues.
MASMTGGQQMGRDPMFKYSRDPM G-[(AG)4]n
^^RMHIRPGAYQLDPAANKARKEAGLAAATAEQ
n= 16or60
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2.4.2 Protein Expression
The host used for protein expression was E. coli strain
BL21(DE3)pLysS." In this strain, a gene encoding T7 RNA
polymerase is incorporated into the bacterial chromosome
under lacUVS control, and protein production is induced by
the addition of IPTG. The pLysS plasmid provides low levels
of T7 lysozyme, which inhibits T7 RNA polymerase and
suppresses the basal level of protein expression.
Protein expression in rich medium was performed as
described in the Experimental Section. Aliquots of cultures
representing approximately equal numbers of cells (as
determined by the optical density at 600 nm) were removed
periodically after induction of protein synthesis (t= 0, 30,
60, 120, 180 min) . Samples were loaded onto a 12.5%
polyacrylamide gel and separated by electrophoresis.
Protein bands were stained with Coomassie Brilliant Blue R-
250. The recombinant protein was insoluble in SDS and did
not migrate during SDS-PAGE; however, increased stain
intensity following induction could be seen in the wells of
the stacking gel (data not shown) indicating inducible
protein production.
Protein production in minimal medium was carried out in
a New Brunswick SOL Mobile pilot plant as described above.
The growth medium (Table 2.1) was adapted from that reported
by Riesenburg et al.^° Oxygenation of the culture must be
maintained in order to insure aerobic growth during the
induction period; otherwise no recombinant protein is
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produced. Oxygen was bubbled through the medium at a flow
rate which maintained the dissolved oxygen content
approximately 20% above the O2 level obtained when the
medium was deoxygenated with N2. After the termination of
batch phase growth (ODgoo = 21) a 50% (w/v) glucose solution
was fed on demand through the pH pump. Upon depletion of
glucose as the carbon source, the culture begins to
metabolize acetic acid previously produced as a result of
glucose metabolism. Depletion of acetic acid results in an
increase in pH; the acid pump is turned on and glucose is
fed to the culture. Acetic acid is then produced, and again
lowers the pH. This allows both the carbon source
(glucose) and the nitrogen source (ammonium hydroxide) to be
fed on demand through the pH control mechanism of the
system. The addition of glucose by pH control is similar to
the method used by Frude et al.,^^ except that in the
present work the base source is also the nitrogen source.
2.4.3 Protein Purification and Analysis
Table 2.2 shows the weight of recombinant protein
produced per gram wet cell weight for cultures of
BL21(DE3)pLysS pET-3b- (AG) 240 grown to optical densities (600
nm) of 1, 10, or 25 prior to protein induction with IPTG.
An optical density of 25 corresponds to approximately 10
cell doublings of the inoculum. There is no loss of protein
produced per gram of wet cell weight (WCW) as the cell
density is increased from 3-4 g WCW/L to 64 g WCW/L prior to
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protein induction. This result indicates that we are not at
the limit of the method, and suggests that these cultures
might be grown to still higher densities with further
increase in the amount of recombinant protein produced per
liter of culture.
Amino acid analyses for both (AG) 54 and (AG) 240 are shown
in Table 2.3. The (AG) 240 Product was found to contain
approximately 5% valine. Two-dimensional NOSY NMR spectra of
the recombinant protein confirmed the presence of valine in
the polymer (Appendix F)
,
suggesting mutation of the coding
sequence subsequent to sequencing of the DNA monomer.
Conversion of alanine to valine was observed previously in
our work on the related polypeptide ( (AG) 4PEG) 14 .^^ The
shorter recombinant molecule does not appear to contain
these changes to valine as determined by amino acid analysis
(Table 2.3)
.
The NMR spectrum of (AG) 64 in formic acid (Figure
2.1) shows the alanine a-proton multiplet at 4.4 5 ppm and
the CH3 doublet at 1.36 ppm. The glycine a-CH2 signal occurs
at 4.05 ppm. The absence of other signals indicates sample
purity, consistent with the results of amino acid analysis
reported in Table 2.3.
The results of elemental analysis are shown in Table
2.4, and are compared with the theoretical analysis for the
product containing 3% water. Addition of 3% water gives
good agreement with the experimental results for carbon and
hydrogen content; we find nitrogen analysis consistently
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lower than theoretical predictions for these kinds of
artificial proteins. ^^'^^
2.4.4 Solid State Properties
Crystalline samples of (AG) 64 were prepared as
described in the Experimental Section. The infrared
spectrum of the crystalline polymer, shown in Figure 2.2,
exhibits amide I and amide II vibrational modes at 1629 and
1529 cm"^ respectively, characteristic of the 3-sheet
conformation.
The wide angle x-ray diffraction photograph, taken with
the x-ray beam directed parallel to the plane of the
compressed mat and with the mat normal horizontal, is shown
in Figure 2.3a. The diffraction photograph exhibits
discrete Bragg diffraction signals consistent with an
oriented crystalline polymer, and all observed signals index
on an orthorhombic unit cell with dimensions a = 0.948 nm,
b = 0.922 nm and c = 0.695 nm. The measured and calculated
inter-planar spacings are listed for comparison in Table 2.5
together with an estimate of the observed intensities. In
addition a set of low angle equatorial diffraction arcs,
orders of 3.2 nm, were seen. This set of diffraction
signals is noticeably different in character from the wide-
angle diffraction signals; the degree of arcing is less by
about a factor of two and they vary in intensity relative to
the wide angle signals in different samples; indeed, in some
cases they are so weak that they are barely detectable,
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except for a diffuse first order at a spacing «3.6 nm.
Their appearance or non-appearance did not change the nature
of spacings of the other diffraction signals.
The orientation direction is along a. Thus the
directionally coincident a and a* axes lie along the
meridian line (vertical bisector)
, and therefore, the hOO
diffraction signals, the easily seen 200 and 400 in
particular, appear as arcs centered on that meridian. The
families of OkO and 001 diffraction signals appear on the
equator (horizontal bisector) . This type of texture-
oriented x-ray diffraction pattern is similar to that
reported previously for poly (AG) jEG. ^^'^^
Differences in the line broadening of the various
diffraction signals, which relate in a consistent way to
their assigned Miller indices, are observed in Figure 2.3a.
The 200 and 400 diffraction arcs are particularly sharp, and
demand long range correlational order along the a-axis.
Diffraction signals with indices of the general hkl type are
considerably broader than those with indices hkO; this
comparison leads us to the conclusion that the coherent
scattering length in the c direction is small. We estimate
a length of 2 to 4 nm (allowing for instrumental line
broadening); this is ca. 16 times less than the length of
the protein chain. The coherent scattering length in the b
direction is intermediate between those in the a and c
directions.
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The wide-angle x-ray photograph taken with the x-ray
beam directed orthogonal to the compressed mat is shown in
Figure 2.3b. The diffraction signals appear as a set of
concentric rings, which index on the orthorhombic lattice
deduced from analysis of the oriented pattern.
The texture-oriented wide-angle x-ray diffraction
photograph shown in Figure 2.3a, obtained with the x-ray
beam parallel to the surface of the mat, is similar to that
previously reported for oriented films of poly (AG) by Fraser
et al.;^^'^^ however, that paper contained no report of any
x-ray diffraction photographs taken with the x-ray beam
orthogonal to the films. The films were stroked during
drying and it was implied that the a-axis is a unique
direction as a consequence, their structure analysis
assumed cylindrical averaging (fiber symmetry) about the a-
axis. In our samples, prepared by compression into mats,
the a-axis is merely confined to the plane of the mat, with
random rotation about the mat normal. It is vital to
recognize there is a texture and to establish its nature if
the x-ray structure analysis is to be performed correctly.
The overall features of our x-ray diffraction pattern are
sufficiently similar to those of Fraser et al."'^^ that we
are confident that we have the same basic crystalline
structure, even if our texture is different.
Fraser et al.,"'^^ proposed the following model. The
structure consists of polar apP-sheets, stacked in pairs
with alanyl faces together and glycyl surfaces together.
respectively. The stacking direction is parallel to the b
axis; the unequal packing of the ap3-sheets is responsible
for the appearance of the 010 diffraction signal.
Successive sheets shear ±a/4 parallel to the a axis
(hydrogen bond direction) in the ac plane. The c axis is
parallel to the chain axis. The only difference between our
unit cell and that reported by Fraser et al."'^^ is the value
of b, the sheet stacking parameter; their reported value of
0.887 nm is 3.8% less than our 0.922 nm-value. A
perspective view of the structure and the unit cell is shown
in Figure 2.4 and a simulated x-ray diffraction pattern
(SXDP) of this structure generated for comparison with the
observed x-ray data is shown in Figure 2.3c. Comparison of
Figures 2.3a and 2.3c shows that although the match between
the observed and calculated diffraction patterns is
reasonably good overall, there are noticeable discrepancies,
the most obvious of which is the unwanted Ikl diffraction
signals on the first layer line. Unwanted first layer line
diffraction occurs even if fiber symmetry is assumed
(although, of course, the relative intensities will be
different) . It can be removed by random shears of ±a/4 in
the ac plane; thus, the model proposed by Fraser et al."'^^
is not correct in detail. In addition there are other
discrepancies between the calculated and experimental x-ray
diffraction patterns; there are unwanted Okl equatorial
diffraction signals in the region between the 010 and 020
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and there is poor agreement with the observed hOO
intensities.
The low-angle equatorial diffraction pattern (which
consists of orders of 3.2 nm) , and the relative broadening
of selected wide-angle diffraction signals favor a chain-
folded lamellar structure for the poly (AG) crystals prepared
in this work. Our interpretation of the poly (AG) x-ray
diffraction results has benefited from the detailed analysis
of poly (AG) 3EG.^^ The appearance of the first few orders of
the 3.2 nm on the equator indicate that the lamellae are
stacking reasonably well at the stacking periodicity of
3.2 nm. In a number of crystal preparations only a diffuse
first order at spacing 3.6 nm (12% greater) was observed.
This is consistent with poorly stacked lamellae. Figure 2.5
shows an orthogonal view (parallel to Jb-axis) of a chain-
folded ap(3-sheet that is consistent with the x-ray data.
The Y~"turns are necessary to generate the polar apP-
sheets.^^ Alanine residues are placed at the apex of each
Y-turn. There are two possible sequences for the y-turns,
either GAG or AGA. Since we knew a priori that the
resolution of the experimental data would not allow us to
delineate the fine details of the fold geometry we chose the
GAG Y-turn as the basis of our model. It should be noted
that the folds on the right-hand edge of the sheet are
conformational ly different from those on the left. A more
detailed perspective view of one of the y-turns is shown in
Figure 2.6. The sheets are stacked by making a rotation, n,
about the a-axis; thus, in the chain-folded lamellar crystal
both surfaces are equally populated with the two types of
fold conformation. With regard to the stacking of the polar
ap3-sheets, there are two possibilities if like surfaces are
to be in contact, either a rotation, n, about the a-axis, or
a rotation, n, about the c-axis. The former structure was
favored since it results in a chain folded lamellar crystal
with both surfaces equally populated with the two types of
fold conformations.
Various structures for poly (AG) were generated by
computer and the stereochemical feasibility of each was
examined using modeling procedures. SXDPs were generated
for comparison with the observed x-ray data. We discovered
that all structures that incorporate regular inter-sheet
shears of ±a/4 parallel to the a axis generate unwanted
intensity for the Ikl diffraction signals. This can be seen
in the SXPD shown in Figure 2.3c, The only way to remove
this intensity is by incorporating random ±a/4 shears in the
ac plane. In addition there are unwanted diffraction
signals on the equator which are removed by alternating +c/2
and -c/2 shears in the ac plane. We have also found this
effect in the structure of poly (AG) 3 EG. A still better
fit can be found if the random shears are only~±a/4. The
closest overall fit with the observed x-ray data is
illustrated in Figure 2.3d, and the final structure is shown
in Figure 2.7.
35
Fraser et al."^'"' did not raise the issue of chain-
folding in the app-sheets of poly (AG), in our recent
studies of related periodic polypeptides''''' crystallized in
very similar circumstances, we have found that the chains
fold regularly through y-turns to form crystalline lamellae
approximately 3-4 nm thick. Chain folding, of course, is an
obvious geometric contender in structures involving
antiparallel chains. We suspect that our slightly increased
value for the average inter-sheet stacking parameter b/2 is
a result of steric interactions at fold surfaces. It was
noticed that the jb-value decreased as the fold period
increased in the series poly (AG) xEG^' as the integer x
changed successively from 3 to 6, which would be consistent
with our suggestion. Further support was found in the
systematic study of the series: poly(AG)3XG, where X varied
from serine to tyrosine; a linear relationship between
increasing volume and increasing Jb-value was established.^"
Given the low degree of polymerization of the poly (AG) used
by Fraser et ai.;^^'^^ it may be that little, if any, chain
folding occurred. No low-angle diffraction features were
reported.
2.5 Conclusions
Poly (AG) has been prepared by biological synthesis in
multigram quantities; 25 g of the recombinant fusion protein
was recovered from 35 liters of culture. This required only
a simple fed-batch fermentation without elaborate feedback
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controls. The observation that there is no decrease in
recombinant protein production with increased cell density
suggests that limiting yields have not yet been reached.
Little or no loss in recombinant protein production with
increased cell doubling also indicates good plasmid
stability in the host strain.
The x-ray diffraction results show that poly (AG) can
crystallize in the form of chain-folded lamellae
approximately 3.2 nm thick. The structure consists of polar
app-sheets folding through yturns. The sheets stack in
pairs with alanyl faces together and glycyl faces together,
respectively, with a stacking periodicity about 4% greater
than that reported previously by Fraser et al.,^^'^^ where
chain folding was not evident. To obtain good agreement
between the calculated and observed x-ray structure factors,
successive sheets must shear randomly ~ ±a/4 and alternately
+C/2 and -c/2 in the ac plane. The calculated diffraction
data are presented in the form of look alike patterns which
are a convenient and, we judge, a stringent test for the
proposed structure.
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Table 2.1 Minimal Medium Composition for High Cell
Density Fermentation
component initial concn.
KH2PO4 13.3 g/L
(NH4)HP04 4.0 g/L
citric acid 1.7 g/L
MgS04-7H20 1.2 g/L
trace metal solution^ 10 mL/L
thiamine hydrochloride 4.5 mg/L
glucose. H2O 27.5 g/L
antifoam 0.1 mL/L
feed solution
glucose 500 g/L
NH2OH 25%
^Trace metal solution: 6 g/L iron (III) citrate, 1.5 g/L
MnCl2-4H20, 0.8 g/L Zn (CH3COO) 2H2O, 0.3 g/L H3BO3, 0.25 g/L
NaMo04-2H20, 0.25 g/L CoCl2'6H2) , 0.15 g/L CuCL2-2H20.
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Table 2.2 Recombinant Protein ((AG),,o Fusion) Recovered from
Cultures of Three Different Cell Densities
ODsoo wet cell recombinant product total
weight (g/L) protein/wet cell yield (g/L) product
weight (mg/g) yield (a
1^ 3 16 0. 048 0. 048
lO" 26 20 0.42 5.2
25'' 64 15 0.96 25
' 1 L overall culture volume
35 L overall culture volume
Table 2.3 Theoretical and Experimental Amino Acid
Analyses for (AG) 64 and (AG) 240
mol % (AG)m mol % (AG)
, 40
amino acid theor
.
exptl
.
theor. exptl
.
aspartic acid 0.00 0.62 0. 00 0.00
alanine 49.23 52.59 49.79 49.00
glycine 49.23 46.28 49.79 46. 54
arginine 0.77 0.51 0.21 0.00
homoserine 0.77 0.21 0.00
valine 0.00 0. 00 0.00 4.45
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Table 2.4 Elemental Analyses of (AG)e4 Including both
Experimental and Theoretical Calculations
element theor
.
theor ± 3%H20 exptl.
carbon 46.85 45.45 45.39
hydrogen 6.33 6.48 6.35
nitrogen 21.86 21.20 19.78
40
Table 2.5 Comparison of Observed Diffraction Signal
Spacings (do) with Those Calculated (d^)
, in Nanometers
(Errors ± 0.002 nm) , for the Orthorhombic Unit Cell of
(AG) Together with an Estimate of Observed Intensities
S = sharp, M = medium, W = weak
(Xo)
(AG)^^: a = 0.948 nm, b = 0.922 nm, c = 0.695 nm
hkl do
010 0 . 922 0.922 S
020 0 .461 0 . 461 s
021 0.375 0 . 384 M
030 0 . 310 0 . 307 M
031 0 . 282 0.281 M
022 0.277
040 0.231 0.231 W
200 0.474 0.474 M (sharp)
210 0.420 0.422 M
211 0.356 0. 360 M (broad)
301 0.282 0.288 M
311 0.275
400 0.237 0.237 W (sharp)
410 0.230 0.230 W
006 0.116 0.116 w
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Figure 2.1. NMR spectrum of (AG) in formyl-d formic
acid taken on a Bruker 500 MHZ NMR spectrometer. The
alanine a CH signal appears at 4.45 ppm and the CH3 peak is
observed at 1.36 ppm. The glycine a CH2 peak protons appear
at 4.05 ppm.
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WAVENUMBERS (cm-1)
Figure 2.2. FTIR spectrum of silk II form of (AG)64- Amide
peaks at 1529 and 1629 indicate the 3-sheet architecture.
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Figure 2.3. X-ray diffraction photographs from poly (AG)
•
(a) With the x-ray beam directed parallel to the plane of
the compressed mat and with the mat normal horizontal. The
diffraction signals on this texture-oriented pattern index
on an orthorhombic unit cell with dimensions: a (hydrogen
bond direction) = 0.948 nm, jb ( inter-ap3 -sheet direction) =
0.922 nm, c (chain direction) = 0.695 nm. Only hOO
diffraction signals occur on the meridian (vertical
bisector) and Okl on the equator (horizontal bisector) . The
low angle diffraction signals are indicated by LX. (b) With
the x-ray beam directed orthogonal to the plane of the
compressed mat. In this case the diffraction signals are a
set of concentric rings which index on the same orthorhombic
unit cell as in (a), c) SXDP of the poly(AG) model proposed
by Fraser et with alternating ±a/4 shears in the ac
plane. Notice the unwanted diffraction intensity on the
first layer line (h=l) as indicated* (d) SXDP of the chain-
folded model shown in Figure 7 which incorporates random
=^±a/4 shears and alternating +c/2 and -c/2 shears in the ac
plane.
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Figure 2.4. Three-dimensional structure generated by a stack
of polar ap3-sheets of poly (AG) . They are arranged so that
like surfaces are in contact; thus the hydrophobic methyl
groups are layered between a pair of ap3-sheets, followed by
a layer of hydrogen atoms. The unit cell is shown; note the
sheets are alternately sheared by ±a/4 in the ac plane. The
alternating deviation from the b/2 stacking periodicity is
evident and is, in part, responsible for the occurrence of
the 010 diffraction signal. The Jb-value is 3.8% greater
than that reported for oriented films of poly (AG) by Fraser
at al.^^ We believe this is due to steric interactions at
the regular (every eighth amino acid) Y"turns in our
structure (see Figure 2.7).
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Figure 2.5. View orthogonal (parallel to Jb-axis) to a single
ap3-sheet of poly (AG), folding in phase with the octapeptide
periodicity and forming Y"turns. The chains (c-direction)
run horizontally and the linear hydrogen bonds (shown as
dashed lines) are directed vertically (a-direction) . Note
that the conformations of the Y"turns are different at the
left-hand and right-hand edges (fold surfaces) of the app-
sheet. The peptides connect through inward-pointing bonds
on the left and outward-pointing bonds on the right. ^'^
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Figure 2.6. Perspective view of a GAG Y"turn (from left-hand
side folds of Figure 2.5). The methyl groups of the alanine
residues on the underside of the ap3-sheet surface can be
clearly seen. The dashed lines represent the hydrogen
bonds. Note the CH3 group at the apex of the Y"turn.
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Figure 2.7. A computer-drawn view of refined structure of
the chain-folded lamellar structure of poly (AG). The SXDP
of this structure is shown in Figure 2.3d and can be
compared with the experimental x-ray photograph shown in
Figure 2.3a.
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CHAPTER 3
DESIGN AND BIOSYNTHESIS OF ELASTIN-LIKE ARTIFICIAL
EXTRACELLULAR MATRIX PROTEINS CONTAINING PERIODICALLY SPACED
CS5/FIBR0NECTIN DOMAINS WHICH BIND HUMAN UMBILICAL VEIN
ENDOTHELIAL CELLS
3 . 1 Abstract
The biosynthesis of artificial extracellular matrix
proteins for use in vascular reconstruction has been
achieved. These proteins are based on an elastin-like
pentapeptide repeat (VPGIG) periodically interspersed with
the CSS region of fibronectin. Both recombinant
(CSS (VPGIG) 20)5 and (CSS (VPGIG) 40) 3 promote adhesion and
spreading of human umbilical vein endothelial cells
(HUVECs) . Although the binding domain (CSS) density is
twice as high in (CSS (VPGIG) 20) 5 as in (CSS (VPGIG) 40) 3, the
number of HUVECs spread on the former is more than twice
that on the latter. This is likely due not only to the
domain density, but to its availability based on the
conformation of the proteins on the surface. This is the
first step in the synthesis of recombinant, artificial
extracellular matrix proteins for tissue reconstruction.
3 . 2 Introduction
Small diameter vascular grafts, < 6mm in diameter, are
plagued by failure. Currently the optimal choice for
vascular reconstruction is autologous saphenous vein if it
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is available and healthy; unfortunately, the patency rate
after 5 years is only 70%/ Polytetraf luoroethylene (PTFE)
and polyethylene terephthalate (PET) are also commonly used
for small diameter vascular grafts; however, the patency
rate of these materials is lower than that of saphenous
vein.^ Failure most often occurs through thrombosis and
occlusion of the graft or through neointimal hyperplasia at
the anastomosis of the vascular grafts.^
Several techniques have been used to improve the
effectiveness of PTFE and PET grafts. Much of the work has
been directed toward achieving a confluent layer of
endothelial cells on the luminal surface of the graft.
Since healthy vessels are lined with a layer of endothelial
cells, which provide a naturally nonthrombogenic interface,
it is thought that a similar layer on a synthetic surface
will also provide a naturally nonthrombogenic surface.
Taking this idea one step further, it is believed that a
combination of the biological nature of saphenous vein
(which is mechanically more similar to the artery that is to
be replaced than are the noncompliant synthetic materials)
along with the naturally confluent, luminal lining of
endothelial cells make saphenous vein superior to PTFE and
PET as a small diameter arterial replacement.^^
We have designed artificial extracellular matrix
proteins''^ exhibiting two main features. They provide
structural support while providing sites for cell adhesion.
These proteins are elastomeric in nature due to blocks of
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(VPGIG) (the one letter amino acid code is used here and
will be used throughout)
. (VPGIG) is known to have a
modulus on the order of 1 x 10*' dynes/cm (depending on
crosslink density and water uptake)" which is similar to
that of native elastin, an extracellular matrix (ECM)
protein. The materials also bind endothelial cells due to
the presence of the CSS region of fibronectin (FN).'" These
artificial extracelluar matrix proteins should provide a
scaffolding for endothelial cells, which can attach and
proliferate, while the cells remodel the ECM to create a
natural environment. The artificial ECM should also
maintain structural support until the seeded cells can
create a native extracellular matrix.
Two techniques are currently available to achieve a
confluent monolayer of endothelial cells on vascular grafts.
Endothelial cells can be induced to grow into the graft by
transinterstitial capillary ingrowth. This has been shown
to be an effective means of endothelializing expanded PTFE
(with a 60 /im internodal distance) in primates^^ and in
canines^^, but has not been shown to be an effective method
in humans. The lack of capillary ingrowth in humans may
have to do with the thin, external, nonporous PTFE wrapping
found on PTFE grafts used for human vascular bypass
surgery .^^
A second technique used to create a monolayer of
endothelial cells on the luminal surface is to preseed the
grafts with endothelial cells. This can be done by
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harvesting autologous endothelial cells and seeding
synthetic grafts immediately prior to implantation;''^'''^ or,
autologous cells can be harvested, cultured and then seeded
onto the graft prior to implantation. ^"'^^ Recent data from
several laboratories has suggested that the patency rate on
these preseeded, synthetic vascular grafts is eguivalent to
that of saphenous vein.^"'^^
The improvement in patency, in humans, of preseeded,
synthetic vascular grafts over those grafts which are
implanted denuded of endothelial cells suggests that seeding
of vascular grafts is indeed a method that, when employed
with new materials, may result in improved vascular
reconstruction. We will herein describe the design,
synthesis and preliminary characterization of novel
artificial extracellular matrix proteins that are expected
to provide not only structural support, but to bind
endothelial cells as well.
Structural support is provided by the pentapeptide
repeat (VPGIG) , a variant of the pentapeptide repeat
(VPGVG) , which has been found to repeat up to 11 times
consecutively in native elastin."^ Polymers composed of
these repeats exhibit an inverse temperature transition,
®°
with a change in temperature causing an entropic expansion
or contraction of the material." Using chemical synthetic
techniques Nicol et al . incorporated RGDS peptides into the
backbone of polymers based on the (VPGVG) peptide. The
proteins were found to bind human foreskin fibroblasts and
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bovine aortic endothelial cells/' In addition, proteins
based solely on (VPGVG) were found to be nonadhesive toward
these cell types.
The cell binding domain used here is the CS5 region of
fibronectin found in the alternatively spliced type III
connecting segment of fibronectin. It is a 20 amino acid
long peptide found to promote cell binding. Humphries et
al
.
found that melanoma cells adhere to the CS5 region
through the a^Pi integrin receptor; more specifically, the
receptors bound to REDV, the minimal sequence necessary for
recognition by a^^i , contained in the CS5 region.
Massia and Hubbell demonstrated that human umbilical vein
endothelial cells (HUVECs) bind to the REDV peptide through
the a^Pi integrin receptor.''^ In further studies the authors
found that the orientation of REDV was quite important for
HUVEC adhesion. GREDVY peptide attached to a glass surface
through the amine terminus promoted HUVEC binding while
peptide bound to the surface through the carboxyl terminus
was not adherent to HUVECs. It was also shown that GREDVY-
grafted surfaces were adherent toward HUVECs, but not toward
smooth muscle cells (SMC), fibroblasts or platelets. ^^'"^
Due to the apparent specificity of REDV for endothelial
cells over other cell types regularly found in the
vasculature, it was chosen for the cell adhesion domain.
The entire CS5 region of fibronectin was chosen because it
was anticipated that the naturally occurring amino acids
surrounding the REDV domain would help to present the
sequence in such a way that it would be recognized by the
a^Pi integrin receptor. Nicol et al . found that chemical
synthetic incorporation of short REDV sequences into a
backbone made primarily of (VPGVG) repeats did not promote
adhesion to the REDV sequences by the a^Pi receptor in
HUVECs/^
Recombinant protein molecules containing either a 20:1
or a 40:1 ratio of (VPGIG) :CS5 have been synthesized. More
specifically, MG (CS5 (VPGIG) 20) sLE and MG (CSS (VPGIG) 40) 3LE have
been synthesized with the elastic portion spanning CSS
regions containing twice as many (VPGIG) repeats in the
latter as in the former. Preliminary results show that
HUVECs do bind to these materials. We find a S-fold
increase in the number of HUVECs bound to the (CSS (VPGIG20) )
5
protein as compared to the (CSS (VPGIG) 40) 3 protein. It is
believed that this adhesion is through the a43i receptor as
anticipated. This achievement is the first step in the
design of precise materials for which biological recognition
elements are engineered in or out depending on the specific
intended use of the material.
3.3 Experimental Section
3.3.1 Materials
T4 DNA ligase, T4 polynucleotide kinase, calf
intestinal phosphatase, and all restriction enzymes were
purchased from New England Biolabs. Ribonuclease A,
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Deoxyribonuclease I, ampicillin, kanamycin and
chloramphenicol were purchased from Sigma Chemical Co.
Escherichia coli strain DH5aF' was purchased from Bethesda
Research Laboratories. Plasmid pUC18 and the XTT cell
counting kit were purchased from Boeringer Mannheim. The
expression plasmid pET-28a and E. coli strain
BL21 (DE3) pLysS^^ were obtained from Novagen. The HUVEC
lines and complete medium were purchased from Clonetics.
Falcon and Corning tissue culture dishes were purchased from
Fisher Scientific. Versine EDTA solution for cell
detachment and M199 serum free medium were purchased from
Gibco.
3.3.2 General Methods
Bacterial growth in rich medium, DNA manipulations and
transformations were performed as described in Sambrook,
Frisch and Maniatis^^. Polymerase chain reactions (PCR)
were run in a Techne cyclogene thermocycler . NMR spectra
were run on a Bruker AMX 500 MHZ spectrometer. Cell density
measurements were done in plastic cuvettes with a path
length of 1 cm at X=600 nm on a Hitachi U2000
spectrophotometer. HUVEC culturing was done according to
Clonetics protocol with the exception that cell detachment
was performed nonenzymatically using 0.02% EDTA (w/v)
.
Briefly, HUVECs were grown in polystyrene tissue culture
flasks with Clonetics EBM complete medium. Cells were grown
to 90% confluence prior to passaging. Cells were passaged 1
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to 6 (i.e., 1/6 of the harvested cells were replated)
. All
manipulations were performed in a laminar flow hood. Cell
cultures were incubated in 5% CO^ incubators at 37 °C. Cell
counting was performed according to the Boeringer Mannheim
XTT cell counting kit instructions; absorption was measured
in disposable cuvettes with a path length of 1 cm at X =
480 nm on a Hitachi U2000 spectrophotometer. Briefly,
0.4 ml of EBM complete medium was added to each well
(containing HUVECs) of a 24 well plate; 0.2 ml of the XTT
reagent was then added to each well. Cells were incubated
with the reagent in the CO2 incubator for 20 hr prior to
reading the absorbance of the medium. Hydrolysis for amino
acid analysis was done using propionic acid and 6.0 M
hydrochloric acid followed by derivatization with phenyl
isothiocyanate (PITC) ; amino acid content was analyzed using
a Waters Picotag System.
3.3.3 Preparation of Synthetic DNA
Oligonucleotides (1-3) were synthesized on a 1 /imol
scale on a Biosearch Model 8700 DNA synthesizer using
phosphoramidite chemistry.^® Crude oligonucleotides were
purified by denaturing polyacrylamide gel electrophoresis
and eluted using the "crush and soak" method." Purified
oligonucleotides were annealed at 80 ""C and allowed to cool
to room temperature over several hours. The annealed
duplexes: CS5 (1), 28ap (2), and (VPGIG)^ (3) were
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phosphorylated with T4 polynucleotide kinase, ethanol
precipitated and dried in vacuo.
(1)
Eco RI(Z) Sal I
I I GEEIQIGHIPREDV DYHL
AATTCTAAGTCGACGGTGAAGAGATCCAGATCGGCCACATCCCGCGTGAAGACGTTGACTACCACCTG
GATTCAGCTGCCACTTCTCTAGGTCTAGCCGGTGTAGGGCGCACTTCTGCAACTGATGGTGGAC
Ban I Xho I Bam HI
Y P
I II
TACCCGGGGGTGCCGCTCGAGG
ATGGGCCCCCACGGCGAGCTCCCTAG
(2)
Nco I Xho I Z Z Sal I
I I
I
CCATGGGCCTCGAGTAATAAAG
CCGGAGCTCATTATT TCAGCT
(3)
Eco RI Z Ban I
j
GjVPGIGVPGIGVPGIGVPGI
AATTCTAAGGGGTGCCGGGTATCGGCGTTCCGGGCATCGGTGTACCGGGCATCGGTGTTCCGGGCATC
GATTCCCCACGGCCCATAGCCGCAAGGCCCGTAGCCACATGGCCCGTAGCCACAAGGCCCGTAG
Ban I Bam HIgvpgig|vp|
ggtgttccgggtatcggggtgccgg
ccacaaggcccatagccccacggccctag
3.3.4 Cloning and Amplification of Synthetic DNA
Purified CSS DNA was ligated into Eco RI/Bam HI
digested pUC18 and used to transform E. coli strain DHSaF'.
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Cells were grown at 37 °C overnight on 2xYT solid medium
containing 200 nq/ml ampicillin, 25 /ug/ml 3-
isopropylthiogalactoside (IPTG) and 40 iiq/ml of the
chromogenic substrate 5-bromo-4-chloro-3-indolyl-3-D-
galactopyranoside (X-Gal) for blue-white screening. Plasmid
DNA from white transformants was sequenced using Sequenase
2.0 (Amersham Life Sciences) to verify the identity of the
insert. After isolation of the recombinant plasmid from a
1 liter 2xYT culture, the CS5 DNA was excised by digestion
with Eco RI and Bam HI and the fragments were separated by
nondenaturing polyacrylamide gel electrophoresis. DNA
monomer was eluted from the polyacrylamide gel by the "crush
and soak" method."
Similarly purified (VPGIG)5 DNA was ligated into Eco
RI/Bam HI digested pUC18 and used to transform E. coli
strain DH5aF'. Cells were grown at 37 °C overnight on 2xYT
solid medium containing 200 /Ltg/ml ampicillin, 25 /xg/ml p-
isopropylthiogalactoside (IPTG) and 40 /xg/ml of the
chromogenic substrate 5-bromo-4-chloro-3-indolyl-3-D-
galactopyranoside (X-Gal) for blue-white screening. Plasmid
DNA from white transformants was sequenced using Sequenase
2.0 (Amersham Life Sciences) to verify the identity of the
insert. After isolation of the recombinant plasmid from a
1 liter 2xYT culture, the (VPGIG)5 DNA was digested with
Ban I and the fragments were separated by nondenaturing
polyacrylamide gel electrophoresis. DNA monomer was eluted
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from the polyacrylamide slice, using the "crush and soak"
method."
Purified 28ap was ligated into Nco I/Xho I digested
pET-28a and used to transform E. coli strain DH5aF'. Cells
were grown overnight on 2xYT solid medium containing 34
/xg/ml kanamycin. Plasmid DNA from single colonies was
sequenced using Sequenase 2.0 (Amersham Life Sciences) to
verify the identity of the insert. The recombinant plasmid
was designated pET-28ap.
3.3.5 Cloning of CSS in Transfer Vector
Purified CSS monomer was ligated into Bam HI/Eco RI
digested pEC2 plasmid DNA (shown in appendix A) . The
resulting plasmid (designated pEC2-CS5) was used to
transform E. coli strain DHSaF'. Cells were grown overnight
on 2xYT solid medium containing 34 nq/ml kanamycin. Plasmid
DNA from single colonies was verified for CSS insert by Bam
HI/Eco RI digestion followed by 1% agarose gel
electrophoresis and visualization of the DNA with ethidium
bromide (EtBr) . The expected band was observed at 100 bp.
3.3.6 Polymerization of the (VPGIG)5 Monomer and Cloning of
(VPGIG)5 Multimers
Purified monomeric (VPGIG)5 DNA was self-ligated with
T4 DNA ligase to form a population of multimers. Multimers
were ligated into Ban I digested, dephosphorylated pEC2-CS5.
The recombinant plasmids were used to transform E. coli
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strain DH5aF •
.
Transformants were screened by PCR" with
cycling times and temperatures as follows: 96 °c, l min;
45 °C, 2 min; 72°C, 2 min with 35 cycles. Vent polymerase
was used with Pst I site primers for pBR322 (New England
Biolabs)
.
Clones encoding 4 and 8 repeats of the (VPGIG)5
monomer were chosen and the recombinant plasmids were
designated pEC2-CS5 (VPGIG) 20 and pEC^-CSS (VPGIG) 40
respectively
.
3.3.7 Construction of Bacterial Expression Vector
Recombinant pEC2-CS5 (VPGIG) 20 or pEC2-CS5 (VPGIG) 40 was
digested with Xho I/Sal I to release the CSS (VPGIG)
^
cassette. The cassettes were separated by 1% agarose gel
electrophoresis and recovered by extraction with Qiaex II
DNA extraction kit (Qiagen) . The recovered DNA was ligated
into Xho I digested, dephosphorylated pET-28ap and used to
transform E, coli strain DH5aF'. Transformants were
screened for the presence and orientation of each multimer
by Pflm I/Xho I digestion. Digested DNA was visualized with
EtBr following 1% agarose gel electrophoresis. Bands
comprising 430 base pairs plus the length of the insert
indicate DNA insertion in the correct orientation. This
process was performed repeatedly to obtain recombinant
plasmids, designated pET-28ap- (CS5 (VPGIG) 20) 5 or pET-28ap-
(CS5 (VPGIG) 40) 3, which were used to transform the expression
host, E. coli strain BL21 (DE3)pLysS.
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3.3.8 Protein Expression, Batch Phase, Rich Medium
Single colonies of BL21 (DE3) pLysS containing
recombinant pET-28ap- (CS5 (VPGIG) 20) 5 or pET-28ap-
(CS5 (VPGIG) 40) 3 were used to inoculate 10 ml of 2xYT medium
containing chloramphenicol (34 /xg/ml) and kanamycin
(34 /Ltg/ml) . The cultures were grown to saturation and used
to inoculate 1 L volumes of 2xYT medium containing
chloramphenicol (34 /Lig/ml) and kanamycin (34 /iig/ml) . The
cultures were grown to ODgoo = 1 at 37 C and protein
expression was induced by the addition of IPTG to a final
concentration of 1.0 mM. Cells were harvested after 3 hours
by centrifugation (5,000 x g, 15 min at 4 °C) . The cell
pellets were resuspended in 15 mL of TEN (50mM Tris-Cl
(pH 8.0), 1 mM EDTA, 100 mM NaCl) and stored at -20 C.
3.3.9 Purification of (CSS (VPGIG) 20)
5
Frozen cells were thawed and phenylmethyl sulfonyl
fluoride (PMSF) (1 mM) , MgCl2 (5 mM) , RNAse (20 ^JLq/ml) and
DNAse (20 /xg/ml) were added to the suspension. The
resulting solution was incubated at 37 °C for 30 min and the
soluble portion was recovered by centrifugation (10,000 x g,
4 °C, 30 min). The supernatant was acidified to pH 5.0 by
addition of 0.1 N HCl and left at room temperature for 1 hr.
The suspension was centrifuged at 10,000 x g for 20 minutes
at room temperature to recover the precipitate. The pellet
was resuspended in 5 ml 1 M urea and incubated at room
temperature for 1 hr, then centrifuged at 10,000 x g for 20
min to recover the soluble portion. The supernatant was
dialyzed (25,000 molecular weight cut off (MWCO) dialysis
tubing, Spectrapore) against H2O at 4 °C for 2 days with H^O
changes. The dialysate was centrifuged to remove impurities
and the supernatant was lyophilized to recover the
recombinant (CSS (VPGIG) 20) 5.
3.3.10 Purification of (CSS (VPGIG) 40)
3
Frozen cells were thawed and phenylmethyl sulfonyl
fluoride (PMSF) (1 mM) , MgCl^ (S mM) , RNAse (20 iiq/ml) and
DNAse (20 /xg/ml) were added to the suspension. The solution
was incubated at 37 °C for 3 0 min and the insoluble portion
was recovered by centrifugation (10,000 x g, 4 °C, 30 min).
The pellet was resuspended in IS ml 1 M urea and incubated
at room temperature for 1 hr, then centrifuged at 10,000 x g
for 20 min to recover the soluble portion. The
supernatant was dialyzed (25,000 MWCO dialysis tubing,
Spectrapore) against H2O at 4 °C for 3 days with H2O
changes. The dialysate was then centrifuged to remove
impurities and the supernatant was lyophilized to recover
the recombinant (CSS (VPGIG) 40) 3 •
3.3.11 Film Casting
Glass coverslips (12 mm) were coated with
(CSS (VPGIG) 20) 5 or (CSS (VPGIG) 40) 3 from solutions in formamide
or water by addition of 40 /xl of a 1 mg/ml solution to the
top surface of the coverslip followed by spreading of the
62
solution with the tip of a pipet. Fibronectin films were
cast from 100 nq/ml solutions in distilled H^OCdH.O); 20 iil
of solution was applied to a glass coverslip and spread with
the tip of a pipet. All coverslips were then dried at 55 °c
in a vacuum oven. Coverslips were incubated in 0.5 ml
sterile H2O at 37 °C for 2 hours to remove excess protein
and again dried in vacuo at 55 °C for 2 hours.
3.3.12 Cell Culturing
Pooled primary HUVECs were cultured and maintained in
Clonetics EBM complete medium in 10 cm Falcon tissue culture
polystyrene petri dishes. HUVECs from passages 2-10, in our
hands, were used for all cell adhesion studies. Cells were
washed with 5 ml phosphate buffered saline (PBS) once and
then harvested using Versine, a 0.02% EDTA solution in PBS.
Harvested cells were resuspended in serum free M199 medium,
counted using a hemocytometer and diluted to a density of
1 X 10'' cells/ml. HUVECs were transferred to 24 well
dishes, 1 x 10'' cells/well, containing protein coated glass
coverslips. Cells were maintained at 37 °C and 5% CO2 for
4 hours and counted using XTT following the Boeringer
Mannheim XTT kit protocol. Briefly, glass coverslips
containing attached cells were removed from the culture
well, washed three times with phosphate buffered saline +
CaCl2 (0.2 g/L) and MgCl2 (0.2 g/L) (PBS+) and placed in new
24 well plates. Endothelial cell medium, phenol red free,
(0.4 ml, Clonetics) and 0.2 ml of cell counting reagent were
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added to each well. Cells were returned to the CO2
incubator for 2 0 hr. The absorbance of the supernatant was
then read at 460 nm.
3.3.13 Cell Counting Calibration
Calibration curves were made during each cell culturing
experiment. HUVECs were cultured at the following
concentrations (2 wells each) in serum free medium: 10,000;
7,500; 5,000; 2,500; 1000; 750; 500; and 250 cells/well.
Cultured cells were maintained in an incubator, 37 °C and 5%
CO2, for 4 hours. After 4 hours the medium was removed; the
HUVECs were washed with 0.5 ml PBS and 0.4 ml of medium
containing serum, and 0.2 ml of cell counting reagent was
added to each well. The calibration wells were maintained
and evaluated as described above.
3.3.14 Cell Adhesion after Removal with Trypsin
Removal of HUVECs from polystyrene dishes was performed
as recommended by Clonetics.
3.4 Results and Discussion
3.4.1 Gene Construction
The strategy used in our laboratory to prepare
artificial proteins has been described previously . In
this work, DNAs encoding two chain-length variants of
CS5(VPGIG), which contain 5' Sal I cohesive ends and 3' Xho
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I cohesive ends were ligated into the Xho I site of the
expression plasmid pET-28ap. The cohesive ends generated by
Xho I and Sal I digestion are the same, and hence can be
ligated; however, the flanking base pairs are different, so
once the ends are ligated the Sal I and Xho I sites are
destroyed. This process maintains an Xho I site at the 3'
end of the gene for addition of DNA cassettes, while
eliminating other restriction sites in the gene so that it
will not be cut into pieces upon enzymatic digestion with
Xho I. This strategy allows for ease in construction of
longer genes. The resulting recombinant plasmids encode
either (CS5 (VPGIG) 20) 5 or (CS5 (VPGIG) 40) 3 (4) and (5)
respectively.
MG(LDGEEIQIGHIPREDVDYHLYP(GVPGI)2o) 5LE (4)
MG (LDGEEIQIGHIPREDVDYHLYP (GVPGI ) 40) 3LE ( 5
)
These genes are constructed in such a way that upon
translation into protein only minimal amino acid fusions are
added to the ends of the protein of interest. A methionine
residue must always be added as it indicates the
translational start; in addition a glycine residue is added
to the start as a result of the use of the Nco I site in
cloning. Two amino acids are also added to the amino
terminus due to cloning into the Xho I site. These
additions result in minimal amino acid fusions.
3.4.2 Protein Expression
The host used for protein expression was E. coli strain
BL21 (DE3)pLysS.^^ In this strain, a gene encoding T7 RNA
polymerase is incorporated into the bacterial chromosome
under lacUVB control, and protein production is induced by
the addition of IPTG. The pLysS plasmid provides low levels
of T7 lysozyme, which inhibits T7 RNA polymerase and
suppresses the basal level of protein expression.
Protein expression in rich medium was performed as
described in the Experimental Section. Aliquots of cultures
representing approximately equal numbers of cells (as
determined by the optical density at 600 nm - 0D,,„„) were
removed periodically after induction of protein synthesis
(t= 0 - 180 minutes) . Samples were loaded on a 10%
polyacrylamide gel and separated by electrophoresis.
Protein bands were stained with Coomassie Brilliant Blue R-
250. The recombinant protein does not stain well; however
it forms a pale blue band which, owing to over-expression
and consequent distortion of the adjacent electric field,
appears to compress lower molecular weight protein bands, as
can be seen near 65,000 da (CS5 (VPGIG) ^o) 3 (Figure 3.1).
Figure 3.1 is a 10% polyacrylamide gel containing whole cell
lysate samples of BL21 (DE3) pLysS pET-28ap- (CS5 (VPGIG) 40) 3
•
Lane 1 contains molecular weight standards while lanes 2
through 5 contain whole cell lysate from cultures at t = 0,
t = 1 hr, t = 2 hr and t = 3 hr respectively. A pale blue
band corresponding to (CS5 (VPGIG) 40) 3 (molecular weight
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59,765 da) can be seen to grow in over the observed
observation period.
3.4.3 Protein Purification and Analysis
For cultures grown to OD^oo = 0.8, 60 mg/L of
(CS5(VPGIG)4o) 1 and 40 mg/L of (CS5 (VPGIG) 20) 5 (molecular
weight 56,984 da) can be recovered through a simple
procedure involving selective precipitation of contaminating
proteins below the lower critical solution temperature of
the target protein.
The and ^^C NMR spectra of (CS5 (VPGIG) 40) j and
(CSS (VPGIG) 20) 5 in formic acid (Figures 3.2 & 3.3) indicate
the presence of the (VPGIG) repeat. As the CS5 regions of
the molecules represent only a few percent of the entire
protein, they are not easily detected by ID NMR; and
therefore the peaks corresponding to those amino acids are
not seen in Figures 3.2a and 3.3a. Splitting of the 3, y
and 5 Pro CH2 can clearly be seen near 3.8-4.0 and 2.0-2.5
ppm due to cis trans isomerization . ® Only one Gly CH2 is
resolved at 2.5 ppm in the proton spectrum; however, both
glycine residues in the pentapeptide repeat are resolved in
the carbon spectrum and are seen as two distinct peaks at
45-46 ppm (Fig. 3.2b & 3.3b). These spectra compare quite
nicely with spectra obtained by McPherson et al . of
recombinant (VPGVG)^, save that of isoleucine peaks
replacing the peaks due to the 4th valine residue as a
result of substitution of He for Val in the pentapeptide.^
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Table 3.1 shows amino acid analysis results for
(CSS (VPGIG) 40)3 and (CS5 (VPGIG) 20) s- Both analyses are in
agreement with the expected protein compositions within the
uncertainty of the measurement. Experimental values
indicate that both the amino acids of the CSS region and the
amino acids of the (VPGIG) region are present in the correct
ratios as are as expected from NMR spectra. The absence of
unassigned peaks in the NMR spectra, combined with the amino
acid analysis, are consistent with sample purity.
3.4.4 HUVEC Adhesion and Spreading
Table 3 . 2 contains cell counting data obtained from
culturing lO'' HUVECs per well in 24 well culture dishes (as
described above) . Each well contained a glass coverslip
coated with protein. As shown, (CSS (VPGIG) 20) 5 and
fibronectin (FN) coated coverslips bind nearly all of the
cells plated into the well. The value for (CSS (VPGIG) 20) 5
cast from H2O is higher than the number of cells plated into
each well; 11,760 cells were counted while only 10,000 were
plated. This can be explained by a small amount of cell
growth during the 20 hour incubation time with complete
medium and XTT cell counting reagent. Significantly fewer
cells are seen to attach to (CSS (VPGIG) 40) 3 cast from water
and from formamide. There are relatively few cells attached
to the glass surface.
Figures 3.4a-e show HUVECs on the surfaces after 4
hours, prior to rinsing with PBS. Greater numbers of HUVECs
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are seen on the (CS5 (VPGIG) 20) 5 surfaces cast from formamide
(Figure 3.4b) and from water (Figure 3.4c) as compared to
the other surfaces. The majority of the cells are spread or
spreading as judged from their nonrefractile nature. Fewer
cells are retained on the (CSS (VPGIG) 40) 3 surfaces cast from
formamide (Figure 3.4d) and water (Figure 3.4e) but, again,
the majority of the HUVECs are spread or spreading.
Although a similar number of HUVECs appear on the glass
surface (Figure 3.4a) and on the (CSS (VPGIG) 40) 3 surfaces,
the majority of the cells on the glass surface are not
adherent as judged from the highly refractile images of the
cells. The artificial extracellular proteins promote cell
attachment and spreading.
Urry and colleagues chemically synthesized
poly{20 (GVGVP)
,
(GREDVP) } . These proteins are random block
copolymers where the ratio of (GVGVP) to (GREDVP) is 20 to
1. They found no adhesion of HUVECs or of A37S melanoma
cells, which are known to express oc^^i, to these materials.
This result may be due to the short (GREDVP) peptide not
achieving the proper conformation for binding to a43i.
Hubbell and colleagues have observed HUVEC spreading on
glycophase glass which has been modified through N-terminal
grafting of GREDVY peptides to the surface at a
concentration of approximately 10 pmol/cm^"^ They report
the percentage of attached cells that are spread, but do not
report the number of cells that are attached. They also
fail to report their criteria for attachment or how to
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define attached vs nonattached/^ These uncertainties make
accurate comparison of results difficult; however, as
determined from protein stability results reported in
chapter 4, 19 ± 2 pmol/cm' of (CSS (VPGIG) 20) 5 is present on
the glass coverslips. Assuming that HUVECs have access to
o
the top 10 A of the recombinant protein film, there is 10 ±
2 pmol/cm' of CS5 ligand available for adhesion (comparable
to that achieved by Hubbell at al.).^^ The attachment and
spreading of HUVECs to (CSS (VPGIG) 40) 3 and (CSS (VPGIG) 20) 5 are
consistent with the results of Hubbell at al . and
attributable to adhesion of the HUVECs to the CSS region.
There are significant differences in the number of
cells attached to surfaces cast from (CSS (VPGIG) 20) 5 and
surfaces cast from (CSS (VPGIG) 40) 3- Although the receptor
density in the former is only twice the density of the
latter, more than twice as many cells attach and spread on
(CSS (VPGIG) 20) 5 ( = 10,000) as on (CSS (VPGIG) 40) 3 ( = 2000) (Table
3.2). This is likely due not only to the density of the
receptor in the protein itself, but to the accessibility of
the receptor once the protein has adhered to a surface.
While the two artificial proteins are quite similar in
primary structure, it is probable that upon adhesion to
glass surfaces their secondary and tertiary structures
become quite different; thus the CSS domain in
(CSS (VPGIG) 40) 3 may not be as accessible to the HUVECs as it
is in the (CSS (VPGIG) 20) 5 protein, due to conformational
differences
.
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Figure 3 . 5a-f show HUVECs that were harvested using
trypsin (Figure 3.5a, 3.5c, 3.5e) and HUVECs that were
harvested using EDTA (Figure 3.5b, 3.5d, 3.5f) spreading on
glass, (CS5(VPGIG)2o)s/ or (CSS (VPGIG)
^o) 3 surfaces after
1 hour in serum free medium. It is evident in all cases
that HUVECs removed from polystyrene culture dishes using
trypsin do not spread as well as HUVECs removed with EDTA.
The difference in spreading of nonenzymatically vs
enzymatically harvested cells on (CSS (VPGIG) 20) 5 cast from
formamide is striking (Figures 3.5c, d, e and f ) . If the
adhesion to (CSS (VPGIG) 20) 5 is mediated by the ot^^i integrin
receptor, as expected, then this difference in adhesion can
be explained. Masumoto and Hemler found that trypsin
cleaves the extracellular domain of the a4 integrin
subunit.^^ Cleavage of the ol^ subunit by trypsin would
inhibit binding by ot^^i to CSS.
3.5 Conclusions
The biosynthesis and purification of (CSS (VPGIG) 20) 5 and
(CS5 (VPGIG) 40) 3 have been successfully achieved as indicated
by polyacrylamide gel electrophoresis, ^H and ^^C NMR
spectroscopy and amino acid analysis. The proteins induce
the adhesion and spreading of HUVECs. It is likely that the
adhesion is through oi^^i integrin recognition of the CSS
block of the proteins.
It is possible to synthesize artificial extracellular
matrix proteins using recombinant DNA techniques. These
71
proteins can be designed in such a way that they provide
support for the growing cells and provide biological signals
specific for these cells. We have demonstrated that we can
design and synthesize elastin-like materials which contain
binding sites for HUVECs. The number of binding sites is
readily varied to control the initial density of the seeded
cells. This approach may be important in the reconstruction
of tissues and organs.
The technique described herein is not limited to
building in a single biological signal. It is equally
possible to choose specifically several signals and build
these simultaneously into one or, should this approach prove
more desirable, into a selected number of different
artificial extracellular matrix proteins. The current work
is a first step in the biosynthesis of biological
scaffolding for the reconstruction of blood vessels.
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Table 3.1 Amino Acid Analyses of (CSS (VPGIG) 20) 5
and (CS5(VPGIG)4o)5
(CSS (VPGIG) 20) s AO) ^
3.(ni.no
acids
theor
.
expl
.
tneor * expl
.
ASP + ASN 2.44 2.22 1,34 2.31
GLU+GLN 3.42 3.03 1 . 94 3.25
SER 0.37 0.64
GLY 34.36 34.01 36.87 33.93
HIS 1.63 1.19 0.9 0.95
ARG 0.81 0.89 0.45 0.82
THR 0.35 0.005
ALA 0.72 1.11
PRO 16.29 17.27 18.8 16.92
TYR 1.63 1.34 0.9 1.09
VAL 17.
1
17.73 17.61
MET
CYS
0.16 0.16 0.15 0.21
ILE 18.73 18.06 19.25 17.77
LEU 1.79 1.92 1.04 1.79
PHE
LYS
0.21
0.44
0.30
0.62
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Table 3.2 Number of HUVECs on Surfaces after
4 Hours in Serum Free Medium
Number of Cells on
Protein / Cast From Surface
Glass 2,880 + 1670
(CS5(VPGIG)2o)5 / Formamide 9, 170 + 1800
(CS5(VPGIG)2o)5 / Water 11,700 + 760
(CSS (VPGIG) 40)3 / Formamide 1,150 + 360
(CS5(VPGIG)4o)3 / Water 2,590 + 570
Fibronectin 10, 140 + 290
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Figure 3.1 A 10% SDS-PAGE of (CSS (VPGIG)
^o) 3 whole cell
lysate is shown. Lane 1 contains molecular weight marker,
bands from top to bottom: 200, 97.4, 68, 43, 29, 18.4, &
14.3 kDa. Lanes 2-5 contain whole cell lysate of t = 0, t =
1^ t=2, &t=3 hrs respectively. The recombinant protein
can be seen as a pale blue band growing into lanes 3-5 at 68
kDa.
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Figure 3.2. NMR spectra of purified (CSS (VPGIG) 40) 3 in
formyl-d formic acid. 3.2a shows the 500 MHz proton NMR
spectrum; all peaks are identified as shown. Identification
of all peaks is consistent with assignments made by
McPherson at al with the exception of the isoleucine
chemical shifts which were assigned independently. 3.2b
shows the carbon-13 spectrum. Only the resonances from the
major amino acid components (VPGIG) can be seen.
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Figure 3.3. NMR spectra of purified (CS5 (VPGIG) 20) s in
formyl-d formic acid. 3.3a shows the 500 MHz proton NMR
spectrum; identification of all peaks is consistent with
assignments made by McPherson et al with the exception of
the isoleucine chemical shifts which were assigned
independently. 3.3b shows the carbon-13 spectrum. Only the
resonances from the major amino acid components (VPGIG) can
be seen.
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Figure 3.4. Phase contrast images of HUVECs spreading on a)
glass, b) (CS5 (VPGIG) ,o) s cast from formamide, c)
(CS5(VPGIG)2o)5 cast from water, d) (CS5 (VPGIG) ,o) 3 cast from
formamide, and e) (CSS (VPGIG) ,0) 5 cast from water.
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Figure 3.5. Phase contrast images of HUVECs harvested
with
Trypsin (5a, 5c, 5e) or EDTA (5b, 5d, 5f ) . Images show
spreading on: a&b) glass, c&d) (CS5 (VPGIG) ,o) s cast from
formamide, e&f) (CS5 (VPGIG) ,o) 3 cast from formamide.
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CHAPTER 4
RECOMBINANT ARTIFICIAL EXTRACELLULAR MATRIX PROTEINS:
CHARACTERIZATION AND CELL - BINDING BEHAVIOR
4 . 1 Abstract
Recombinant artificial extracellular matrix proteins
have been evaluated as materials for use in the design of
new vascular prostheses. Two proteins (CSS (VPGIG)
.,o) , and
(CSS (VPGIG) b which contain the CSS region of fibronectin,
known to bind to the a^^-^ integrin receptor/' and an elastin
like pentapeptide (VPGIG) have been cast into films upon
which human umbilical vein endothelial cells (HUVECs) were
cultured. These proteins promote the adhesion and spreading
of HUVECs. The number of cells adherent to the surface is
dependent on the density of the CSS domain with
(CSS (VPGIG) 2o) 5 exhibiting 5 times the number of adhered
cells as (CSS (VPGIG) 4o) 3* The extent of individual cell
spreading is seen to be similar on both materials. Adhesion
of HUVECs to these materials supports the formation of actin
filaments as shown by fluorescent staining of the actin.
The existence of the LOST in both materials suggests that
they retain the properties of the elastin-like backbone
despite the periodic insertion of CSS.
4.2 Introduction
It has been well documented that cells respond to the
surface with which they are in contact. These surfaces may
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be biological in nature and thus contain biospecific
moieties that signal the cells to respond in a defined
manner, or they may be synthetic materials that, due to
their chemical or physical properties, signal the cells in a
nonspecific fashion. Grande et al . demonstrated that
chondrocytes cultured in vitro on polyglycolic acid produce
proteoglycans, while chondrocytes cultured on type I
collagen produce primarily collagen/'^ Peluso et al . found
that poly (hydroxyethyl methacrylate) P(HEMA) supported
minimal fibroblast attachment and spreading, while an
interpenetrating polymer network containing 10 wt %
polycaprolactone and 90 % P(HEMA) induced cell spreading and
stimulated a 4-5 fold increase in collagen production by the
fibroblasts.®^ By functionalizing polyethylene with COOH,
CH2OH, CONH2, and CH2NH2 groups (using corona discharge
treatment), Lee et al . found that they could change the
ability of Chinese hamster ovary cells to adhere, spread and
grow on the surfaces; the positively charged CH2NH2 surface
was found to maximize these behaviors.®^ By altering the
surface charge of poly (vinylidene fluoride) (PVDF) , Bouaziz
et al. demonstrated that the secretion of prostacyclin and
thromboxane by endothelial cells cultured on these surfaces
varied; PVDF with a piezoelectric coefficient of 25pCN
^
showed the highest prostacyclin : Thromboxane A2 ratios.
Controlling the behavior of the cells on surfaces
offers the best possibility for the reconstruction of
tissues and organs. Artificial extracellular matrix
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proteins can be designed with built-in control of both the
mechanical and biological properties of the resulting
material. Recombinant DNA technology provides a powerful
technique with which these novel artificial extracellular
matrix materials can be synthesized. We have previously
reported the synthesis of two such proteins: (CS5 (VPGIG) 20)
5
and (CSS (VPGIG) 40) 3, in which the CS5 designates the CS5
region of f ibronectin. The REDV sequence, contained
within the CSS peptide, was shown to be the minimal sequence
necessary to bind to the a43i integrin."" Massia at al
.
found that the a43i integrin is present in human umbilical
vein endothelial cells (HUVECs) and that this HUVEC receptor
adheres to both soluble and surface-grafted GREDVY
peptide.''^ The authors also reported that the peptide does
not promote the adhesion and spreading of fibroblasts,
smooth muscle cells (SMC) or platelets when bound to
glycophase glass. ^^'''^
In our biosynthetic constructs the (VPGIG) block
provides the mechanical support. The (VPGIG) ^ structural
block is based on the pentapeptide (VPGVG) which, when
polymerized has been shown by Urry to have mechanical
properties similar to those of native elastin.®^ These
proteins are elastomeric in nature due to blocks of (VPGVG)
known to have a modulus on the order of 1 x 10^ dynes/cm^
(depending on crosslink density and water uptake)^ similar
to native elastin, an extracellular matrix (ECM) protein.
These new artificial extracellular matrix proteins are
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expected to provide structural support while promoting the
adhesion and spreading of HUVECs through the a^^^ integrin
receptor. It is also anticipated that they will selectively
bind HUVECs and not fibroblasts, platelets and SMC due to
the specificity of the REDV peptide. ^^'"^ In addition, a
similar polymer, (VPGVG)^, was found by Nicol et al . not to
support the adhesion of ligamentum nuchae fibroblasts, human
malignant melanoma cells and HUVECs. "^'"^
As reported in the previous chapter, HUVECs adhere to
(CSS (VPGIG) 40)3 and (CSS (VPGIG) 20) 5. This adhesion is thought
to be moderated by the REDV sequence contained in the CSS
block of the proteins. These novel materials also promote
the spreading of HUVECs and support cell growth and
monolayer formation.
It has been reported that similar proteins based on
(VPGVG)x, when crosslinked using gamma-irradiation, exhibit
elastomeric properties. ^^'^^ By analogy, the present
artificial extracellular matrix proteins are expected to be
elastomeric in nature. HUVEC adhesion and elasticity are
favorable qualities for vascular prostheses. These grafts
would be expected to provide elastic recoil during diastole,
match the compliance of native artery, and promote the
formation of a confluent endothelium. These proteins are
the first step in the design of vascular grafts that will
promote cell adhesion and growth as well as provide
mechanical support which is similar to that found in native
arteries. Furthermore, such materials are expected to
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degrade into nontoxic biological molecules which can then be
utilized by the body in protein production while the cells
are remodeling their own extracellular matrix. Finally,
materials based on the pentapeptide (VPGVG)
,
poly(VPGVG)^
as well as crosslinked poly (VPGVG) (20 mrad y-irradiation)
have been subjected to extensive biomaterials testing,
including determination of mutagenicity (Ames test)
,
toxicity (mice and rabbits)
,
antigenicity (Guinea pigs)
,
pyrogenicity (rabbits) and thrombogenicity (dogs) and have
performed well in each of these tests. ®^
4.3 Experimental Section
4.3.1 Materials
HUVEC and human aortic SMC lines as well as medium were
purchased from Clonetics. M199 serum free medium and
Versine were purchased from Gibco. The XTT cell counting
kit was purchased from Boeringer Mannheim. Falcon 10 cm and
Corning 24 well tissue culture dishes and 12 mm glass cover
slips were purchased from Fisher Scientific. Mouse
monoclonal anti human a4 (P4G9) was purchased from Life
Technologies. Mouse anti human monoclonal B-5G10 was a
kind gift from Martin Hemler at the Dana Farber Cancer
Institute. Oregon Green™ 488 phalloidin was purchased from
Molecular Probes. Vecta Shield mounting fluid was obtained
from Vector Research Laboratories. The GREDVDY peptide was
obtained from Research Genetics, Inc. Ultima Gold
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scintillation counting fluid was purchased from Packard
Instrument Company.
4.3.2 General Methods
HUVECs were maintained in EBM complete medium
(Clonetics) and SMC in SmGM Bullet kit {containing basal
medium, 10 Mg/L Epidermal Growth Factor, 2 /xg/L Fibroblast
Growth Factor, 0.39 mg/L Dextramethasone, 50 mg/ml
Gentamicin, 50 mg/ml Amphotericin-B, and 10 % Fetal Bovine
serum (Clonetics) } in a humidified, 5% CO2 incubator at
37 °C as specified by Clonetics' protocol (described briefly
in chapter 3) with the exception that cell detachment was
performed nonenzymatically . Cloud point curves were
obtained in distilled water in quartz cuvettes with a
pathlength of 1 mm at X = 300 nm on a Jasco Model J-715
spectropolarimeter equipped with a Peltier type temperature
control system; Jasco J-700 for Windows software was used
for data analysis. Scintillation counting was performed
using a Beckman Instruments, Inc. LS 1800 scintillation
counter. Confocal images were obtained with a BioRad MRC
1000 confocal microscope.
4.3.3 Protein Expression, Batch Phase, M9AA Medium
Single colonies of E. coli strain BL21(DE3)pLysS
transformed with recombinant pET-28ap- (CSS (VPGIG) 20) 5 or pET-
28ap-(CS5(VPGIG)4o)3 (cf. previous chapter) were used to
inoculate 5 ml of M9AA medium containing chloramphenicol
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(34 /ig/ml) and kanamycin (34 /Lig/ml) . The cultures were
grown to saturation and used to inoculate 0.5 L volumes of
M9AA medium containing chloramphenicol (34 /xg/ml) and
kanamycin (34 ng/ml) . The cultures were grown to ODgoo = 0.8
at 37 °C and protein expression was induced by the addition
of IPTG to a final concentration of 1.0 mM; 2 ml 1 ^,Ci/^l
(0.13-0.27 mmol) glycine was added for radiolabeling of
the artificial protein. Cells were harvested after 3 hours
by centrifugation (5,000 x g, 15 min at 4 °C) . The cell
pellets were resuspended in 7 mL of TEN (50mM Tris-Cl (pH
8.0), 1 mM EDTA, 100 mM NaCl) and stored at -20 °C.
4.3.4 Protein Purification (CS5 (VPGIG) 40) 3 and (CS5 (VPGIG) 20)
5
Frozen cells were thawed and phenylmethyl sulfonyl
fluoride (PMSF) (1 mM) , MgCl2 (5 mM) , RNAse (20 /ig/ml) and
DNAse (20 /Ltg/ml) were added. The solutions were incubated
at 37 °C for 3 0 min and the insoluble portion was recovered
by centrifugation (10,000 x g, 4 °C, 30 min). The pellet
was resuspended in 7.5 ml 1 M urea ( (CS5 (VPGIG) 20) 5 is found
in the insoluble fraction when grown in minimal medium)
,
incubated at room temperature for 1 hr, then centrifuged at
10,000 rpm for 20 min to recover the soluble portion. The
supernatant was dialyzed (25,000 molecular weight cutoff,
MWCO, dialysis tubing, Spectrapore) against 4° C H2O for 3
days with H2O changes. The dialysate was then centrifuged
to remove impurities and the supernatant was lyophilized to
recover the recombinant (CS5 (VPGIG) 40) 3 or (CS5 (VPGIG) 20) 5.
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4.3.5 Cloud Point Measurements
The lower critical solution temperature (LCST)
, or
cloud point, was determined as a function of concentration
for both (CS5(VPGIG)2o)5 and (CSS (VPGIG)
^o) 3. For each -
protein solutions of 4, 8, 12, and 16 mg of the protein in
400 Ml of distilled H2O at 4 "C was prepared. Quartz
cuvettes (l mm) were filled with 300 /xl of solution and
temperature was scanned from 10 °C to 15 °C at a rate of 6
°C/hr. Percent transmittance was measured at 300 nm.
4.3.6 Film Casting
Glass coverslips (12 mm) (presoaked for 24 hr in
concentrated H2SO4 and repeatedly rinsed with distilled H2O)
were coated with (CS5 (VPGIG) 20) 5 or (CS5 (VPGIG) 40) 3 from
solutions in formamide or water by addition of 40 iil of a
1 mg/ml solution to the top surface of the coverslip
followed by spreading of the solution with the tip of a
pipet. Fibronectin films were cast from 100 jug/ml solutions
in distilled H2O; 20 /il of solution was applied to a glass
cover slip and spread with the tip of a pipet. The
coverslips were then dried overnight at 55 °C in vacuo.
Coverslips were incubated in 0.5 ml sterile H2O at 37 °C for
2 hours to remove excess protein and again dried in vacuo at
55 °C for 2 hours.
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4.3.7 Stability of Protein Coatings
Tritiated (CSS (VPGIG) 20) 5 and (CSS (VPGIG)
^o) 3 were cast
on glass surfaces as described previously. Phosphate
buffered saline (PBS, O.S ml) was added to 24 well culture
dishes containing coverslips coated with tritiated protein.
To determine the accumulation of protein in solution over
time, 10 /ul aliquots of PBS were removed at 3 0 min intervals
and transferred to scintillation vials containing 4 ml of
scintillation counting fluid. Each coating was analyzed in
triplicate. To determine the amount of protein removed with
repetitive washing, O.S ml aliquots of PBS were transferred
from the wells to scintillation vials at 30 min intervals.
Fresh PBS was added to the wells. These steps were repeated
over a period of 3 hours and each surface was analyzed in
triplicate. After three hours the glass coverslips were
removed from the wells, rinsed briefly with PBS and placed
in scintillation vials to determine the amount of protein
remaining on the surface. Untreated glass surfaces were
used in each case as controls.
4.3.8 Cell Culturing and Morphology
Pooled primary HUVECs were cultured and maintained in
10 mm Falcon petri dishes. HUVECs from passages 2-10, in
our hands, were used for all cell adhesion studies. Cells
were washed with 5 ml phosphate buffered saline (PBS) once
and then harvested using Versine, a 0.02% EDTA solution in
PBS. Harvested cells were resuspended in M199, serum free
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medium, counted using a hemocytometer and diluted to a
density of 5 x lo' cells/ml. HUVECs were transferred to 24
well dishes, 5 x lo' cells/well, containing protein coated
glass coverslips. Cells were maintained at 37 °c and 5% CO2
for 4 hours and fixed using 3.7 % formaldehyde in PBS.
Briefly, glass coverslips containing attached cells were
removed from the culture well, washed three times with
phosphate buffered saline + CaCl2 (0.1 g/1) and MgCl, (0.1
g/1) (PBS+) and placed in new 24 well plates. Cells were
fixed by addition of 0.5 ml 3.7 % formaldehyde in PBS for 1
hr at 4 °C followed by washing with distilled H2O. Pictures
were taken of two different wells for each surface on a
phase contrast microscope. Cell morphology was evaluated
from the photographs.
4.3.9 Competitive Inhibition
HUVECs were detached from 10 cm Falcon petri dishes and
counted as described above. Cells were resuspended in M199
serum free medium at a concentration of 6 X lO'' cells/ml.
GREDVDY (Research Genetics) peptide was added to the cell
suspension to achieve the following final concentrations:
0.0, 0.2, 0.4, 0.6, 0.8, and 1.0 mg peptide/ ml suspension.
The suspensions were incubated in a 37 °C water bath for 30
min followed by dilution to 1 x 10^ cells/ml and addition to
the tissue culture wells. HUVECs were maintained at 37 °C
and 5% CO2 for 4 hours and observed and photographed under
the phase contrast microscope.
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4.3.10 Actin Filament Staining
HUVECs were harvested and counted as described
previously, diluted to 5 x 10^ cells/ml in serum free M199
medium, and plated on coverslips coated with (CS5 (VPGIG) 20)
cast from formamide. Plated cells were incubated at 37 °C
and 5% CO2 for 4 hours, washed with PBS twice and fixed for
5 min with 3.7 % formaldehyde (from paraformaldehyde) in
PBS. The cells were again washed twice with PBS and fixed
and permeabilized in PBS with 0.5% Triton x-100 and 3.7%
formaldehyde for 5 min at 0 °C. Cells were then washed
several times with PBS and incubated for 10 min with PBS +
0.2 % BSA. Oregon Green™ conjugated phalloidin (5 |xL,
Molecular Probes) was then added to each well with 500 /LtL
PBS. Cells were incubated at 37 °C for 30 min and washed
well before mounting on microscope slides using Vecta
Shield. Cells were visualized with a confocal microscope.
4.4 Results and Discussion
Proteins composed of repeats of the pentapeptide
-VPGVG- exhibit a LCST at approximately 2 5 °C as shown by
Urry and Long.^^ Urry at al . went on to show that the
temperature at which the phase transition occurs can be
altered by varying the residue at the fourth position (X)
the -VPGXG- pentapeptide; inclusion of a more hydrophobic
residue reduces the LCST while a more hydrophilic residue
raises the transition temperature. ^° Figure 4.1 shows the
LCST behavior of (CS5 (VPGIG) 20) 5 and (CS5 (VPGIG) 40) 3 in
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40 mg/ml aqueous solutions. Consistent with the predictions
of Urry et al
.
, we find that the inclusion of the more
hydrophobic isoleucine residue reduces the transition
temperatures to 12.1 and 13.4 °C respectively for the two
polymers as measured by cloud point analysis on 4 0 mg/ml
solutions as described above. However, Urry et al . predict
that the transition temperature of the proteins should be
reduced to 10 °C.^° Our slightly greater values may be due
to the incorporation of the CSS domain within the proteins.
On the other hand, the LOST of (CS5 (VPGIG) 40) 3 is 1.3 °C
higher than (CS5 (VPGIG) 20) 5 while the former has pentapeptide
blocks 200 amino acids long as compared to 100 amino acids
in the latter. This argument would indicate that the LOST
of the pentapeptide (VPGIG) itself would be greater than
13.4 °C. This contradictioncan only be resolved when the
cloud point data of the polypentapeptide becomes available.
Retention of the LCST may be consistent with retention of
the elastomeric nature of the proteins.
Despite the existence of an LCST below body
temperature, small quantities of the material are soluble in
aqueous solution at 37 °C; the two phase system is composed
of a protein rich phase and a protein poor, but not protein
free, phase. To determine if sufficient protein remains on
glass surfaces for full coverage after addition of the
aqueous cell culturing medium, glass coverslips were coated
with tritiated protein and soaked in PBS as described.
Figure 4.2 shows the accumulation of (CS5 (VPGIG) 20) 5/ cast
from formamide, in solution over a 3 hour time period. The
majority of the protein is dissolved within the first hour
with very little protein being removed thereafter. The
other three protein cast films behave in a similar manner
(data not shown)
.
Table 4 . 1 shows the amount of protein removed over a
three hour period for both the case where the coverslips are
soaked in 0.5 ml PBS for 3 hours and when the PBS is removed
every 3 0 minutes and replaced with 0.5 ml aliquots of fresh
PBS. Also shown is the amount of protein remaining on the
glass coverslips at three hours. In all cases 2-3 jixg of
(CS5(VPGIG)4o)3 and approximately 1 /xg of (CSS (VPGIG) 20) 5 were
found on the coverslips after thorough washing. There is a
discrepancy of 8-10 fiq of protein being cast and protein
being detected in all cases. Although experimental error
can account for some of this discrepancy, there is still
several unaccounted j^tg. Since much of the protein goes into
solution within the first several minutes, there is a
protein solution in contact with the polystyrene tissue
culture well for 3 hours. Protein is likely to have adhered
to the polystyrene well, which has a surface area 3 times
that of the coverslip.
Cast films were presoaked for 2 hours to remove the
excess protein prior to addition of the cells in serum free
medium.
Table 3.2 reports the number of cells adhered to the
cast surfaces of the two artificial extracellular matrix
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proteins, glass and fibronectin. We found that essentially
all cells cast on fibronectin and on (CSS (VPGIG) 20) 5 were
adherent, while only about 25% of the cells cast on glass
and (CS(VPGIG)4o)3 were adherent. We attribute the decrease
in the number of cells bound to (CS5 (VPGIG) 40) 3 as compared
to (CSS (VPGIG) 20) 5 to the lower CSS density in the former,
and possibly to a difference in protein conformation upon
adsorption to the glass surface which may present the REDV
sequence in a less than optimal manner. Table 4.2 tabulates
the cell morphologies when attached to these surfaces.
Refractile cells are seen to be round and bright under the
phase contrast microscope, cells which were round but not
highly refractile were classified as round and grey,
spreading cells exhibited 1-2 pseudopodia, while spread
cells had >2 pseudopodia. Not only did the glass surface
support far fewer cells than (CSS (VPGIG) 20) 5/ but half of the
cells on glass are highly refractile. In contrast, although
(CSS (VPGIG) 40) 3 supports approximately the same number of
adherent cells as does glass, < 20% of the HUVECs on
(CSS (VPGIG) 40) 3 are highly refractile; in this case half the
cells are well spread. The morphology of the cells on
(CSS (VPGIG) 20) 5 is similar to that on (CSS (VPGIG) 40) 3/*
however, the number of attached cells is 4 times as great.
Although the data are not shown in table 4.2, all cells
plated on fibronectin are well spread after 4 hours in serum
free medium.
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Hubbell and colleagues have observed HUVEC spreading on
glycophase glass which has been modified through N-terminal
grafting of GREDVY peptides to the surface at a
concentration of approximately 10 pmol/cm'J' As determined
from protein stability results 19 ± 2 pmol/cm^ of CSS are
present on the glass coverslips. Assuming that HUVECs have
access to the top 10 A of the recombinant protein film,
there is 10 ± 2 pmol/cm^ of CSS ligand available for
adhesion (compare to 10 pmol/cm^) ."^ They report the
percentage of attached cells that are spread to be 89 %.
Defining all nonrefractile cells as spread or spreading, we
find that -80 % of attached cells are spread on both
(CSS (VPGIG) 40)3 and (CSS (VPGIG) 20) 5, which is consistent with
results obtained by Hubbell and colleagues with similar
ligand densities. Although the percent of well spread
HUVECs on fibronectin is higher than that on (CSS (VPGIG) 20)
5
cast from either water or formamide, upon addition of
complete medium containing 2 % serum all of the HUVECs on
the artificial extracellular matrix protein become well
spread within an hour. Both the fibronectin surfaces and
the (CSS (VPGIG) 20) 5 surfaces go on to become confluent in 36-
48 hours.
Figures 3.4a-3.4e show HUVECs on glass (3.4a),
(CSS (VPGIG) 20) 5 cast from formamide and water respectively
(3.4b, 3.4c) and (CSS (VPGIG) 40) 3 cast from formamide and
water (3.4d, 3.4e). The differences in cell numbers and
cell morphology can be seen clearly. Figure 4.3a-b shows
confluent monolayers of HUVECs on fibronectin and on
(CS5(VPGIG)2o)5 respectively. In both cases the expected
cobblestone morphology is observed.
Preliminary measurements of competitive inhibition of
EC attachment by soluble CS5 analogues have also been made.
As expected, pre-incubation of HUVECs with the soluble
peptide GREDVDY (Research Genetics, Inc.) at concentrations
up to 2 mg/ml has no observable effect on attachment to
fibronectin. In contrast, attachment to (CSS (VPGIG) 20) 5 is
completely inhibited by GREDVDY at concentrations of 0.6-0.8
mg/ml. Although this result is consistent with specific
attachment of HUVECs to CSS via the a^^^ receptor, we have
not yet conducted controls with sequence-scrambled analogues
of the inhibitory peptide.
Figure 4.4 shows actin filament staining of a HUVEC
spread on (CSS (VPGIG) 20) i, using Oregon Green conjugated
phalloidin. Actin filaments (Figure 4.4a) can be seen
clearly on the periphery of the cell, in addition, some
filaments can be seen (Figure 4.4b) that originate from near
the center of the cell and reach out toward the periphery.
Upon adhesion and spreading, many cells form actin filaments
or stress fibers. These filaments play a role in the
anchorage and movement of membrane proteins and in the
locomotion of cells. ^° In addition, many integrins,
including ol^^i/^ bind both actin filaments and extracellular
matrix proteins and thereby serve as a link between the
interior and the exterior of the cells.
4.5 Conclusions
Both (CS5(VPGIG)2o)5 and (CSS (VPGIG) 40) 3 support adhesion
and spreading of HUVECs. The presence of actin filaments as
seen in the Oregon Green™ conjugated phalloidin confocal
images of HUVECs spread on (CS5 (VPGIG) 20) 5 (Figures 5a & b)
is suggestive of a well organized cytoskeleton.
Morphological data shown in Table 4.2 suggests that more
than 7 0% of the adherent cells are spread, and the number of
cells bound to (CS5 (VPGIG) 20) 5 is similar to the number bound
on fibronectin (Table 3.2). The morphology of the cells
spread on (CS5 (VPGIG) 40) 3 is similar to that of cells on
(CS5 (VPGIG) 20) 5 as shown in Table 4.2. This equivalencce
suggests that by changing the density of ligand we can
control the number of cells that attach to a material
without affecting the extent of individual cell spreading.
In addition, as seen in Figure 4.3 b, (CS5 (VPGIG) 20) 5
supports HUVEC monolayer formation subsequent to the
addition of serum, which is necessary for optimal vascular
regeneration.
Competitive inhibition data suggests that the HUVECs
are binding to the artificial extracellular matrix proteins
through the CS5 region. Preincubation with soluble GREDVDY
has no effect on HUVECs' ability to adhere to fibronectin,
indicating that the peptide is not inhibiting adhesion to
all surfaces. In contrast, as the concentration of GREDVDY
peptide with which the HUVECs are incubated increases, the
number of cells that adhere to the artificial extracellular
matrix proteins decreases. The soluble peptide inhibits
cell adhesion by blocking the 04^1 integrin through binding
to the receptor in solution. The receptor is then unable to
bind to the CS5 domain of the proteins. This inference
also suggests that the pentapeptide repeat does not support
cell adhesion, as blocking of adhesion to the REDV sequence
contained within the CS5 block inhibits cellular adhesion.
This conclusion will only be confirmed when synthesis of the
pentapeptide alone is complete and HUVEC adhesion to this
material can be tested. Further evidence of adhesion
through the CSS domain is the increase in number of cells
adhered to (CS5 (VPGIG) 20) 5 as compared to (CSS (VPGIG) 40) 3/ the
latter having a S0% decrease in ligand density.
These materials also retain some of the characteristics
of the elastin portion of the proteins as suggested by the
observation of the LCST. Both of the recombinant proteins
exhibit an LCST despite the fact that the elastin segments
are interrupted by the CSS region. Despite the occurrence
of the LCST near 13 °C for both materials, they are water-
soluble in low concentrations at 37 °C; however, complete
coverage of the glass coverslips after incubation in aqueous
medium for two hours was confirmed by SEM (data shown in
Appendix D) and scintillation counting.
We have synthesized artificial extracellular matrix
proteins which contain specific cell binding domains as well
as structural blocks that are expected to mimic native
elastin. Control of the density of adhesion ligand controls
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the number of cells adherent to the materials. In addition,
preliminary work by Kathy DiZio in our laboratory suggests
that there is little or no smooth muscle cell adhesion to
(CS5 (VPGIG)2o) 5f consistent with the work of Hubbell et al .^^
using GREDVY grafted to glass surfaces.
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Table 4.1 Determination of Protein Stability on
Glass Covers lips
0.5 ml PBS for 3 hrs 0.5 ml PBS
every
exchanged
30 min
polymer/
casting
solvent
accumulation
in solution
remaining on
coverslip
total
solubilized
Mg
remaining on
coverslip
(CS5(VPGIG)2o)5
Formamide
29.2 ± 0.7 2.0 ± 0.6 32.6 ± 2.9 0.6 ± 0.2
(CS5(VPGIG)2o),
Water
30.9 ± 1.3 0.8 ± 0.3 30.3 ± 1.9 0.5 ± 0.1
(CS5(VPGIG),o)j
Formamide
24.4 ± 4.9 3.2 ± 1.2 23.5 ± 2.5 3.6 ± 0.6
(CS5(VPGIG),„)
,
26.1 ± 1.4 1.9 ± 0.4 28.5 ± 1.3 1.2 ± 0.5
Water
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Table 4.2 HUVEC Morphology on Glass and Protein
Cast Surfaces.
Protein/ Refractile Round/Gray Spreading Spread
Cast From % % % %
Glass 49.5 ± 8.6 12.0 ± 0.4 13.4 ± 2.3 25.1 ± 7,8
(CS5(VPGIG)2o)5 15.2 ± 5.9 14.6 ± 3.4 14.4 ± 5.0 55.8 ± 3.9
Fortnamide
(CS5(VPGIG)2o)5 20.9 ± 5.3 11.4 ± 4.9 11.6 ± 1.4 55.8 ± 9.3
Water
(CS5(VPGIG)4o)3 14.1 ± 1.2 15.9 ± 5.9 21.3 ± 2.5 48.7 ± 2.2
Formamide
(CS5(VPGIG)4o)3 18.7 ± 7.2 16.3 ± 5.5 7.9 ± 4.0 53.7 ± 6.6
Water
Spreading = 1-2 pseudopod
Spread = > 2 pseudopod
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TEMPERATURE C
Figure 4.1. LCST data of (CS5 (VPGIG) 20) 5 and (CSS (VPGIG) ^o) 3in aqueous solution (40 mg/ml)
.
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Figure 4.2. Accumulation of - Glycine labeled
(CSS (VPGIG) 2o) 5 in solution over 3 hours. Films were cast
from formamide (total protein cast 40 /xg) and soaked in PBS
at 37 °C for 3 hrs. The majority of the solubilization
occurs within the first hour.
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b.
Figure 4.3. Confluent layers of endothelial cells are
supported by both fibronectin coated glass surfaces (4.3a)
and (CSS (VPGIG) 20) 5 coated glass surfaces (4.3b). In both
cases the expected cobblestone morphology is seen.
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Figure 4.4. HUVECs which are allowed to adhere to
(CS5 (VPGIG) 20) 5 for 4 hours in serum free medium are spread.
Oregon Green^^ conjugated phalloidin was used to visualize
actin filaments which can be seen at the periphery of the
cell (4.4a) and extending from the center of the cell to the
periphery (4 . 4b)
.
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CHAPTER 5
CONCLUSIONS AND FUTURE PERSPECTIVES
Recombinant extracellular matrix proteins have been
successfully synthesized as shown by SDS-PAGE, NMR
spectroscopy and amino acid analysis. (CS5 (VPGIG) 20) 5 and
(CS5(VPGIG)4o) 3 were designed with the intent that the
pentapeptide repeat (VPGIG) 20,40 would provide the structural
integrity of the material^^'^^'®^ while the CSS block would be
the ligand for HUVEC binding through the oc^^^^^'^^'^^ integrin
receptor.
Both recombinant artificial extracellular matrix
proteins support the adhesion of HUVECs. Competitive
inhibition studies with soluble GREDVDY suggest that the CSS
region is indeed the ligand for HUVEC adhesion to the
artificial extracellular matrix proteins.
Further support for the supposition that HUVECs are
binding primarily through the CSS domain of the polypeptides
comes from data showing that significantly fewer HUVECs bind
to (CSS (VPGIG) 40) 3 than bind to (CSS (VPGIG) 20) s- The former
contains S0% fewer CSS blocks per pentapeptide repeat. Thus
lower HUVEC adhesion to the former is consistent with
binding to the CSS block. This trend again suggests that
the pentapeptide repeat does not promote cell adhesion.
The relationship between the density of the adhesion
ligand and the number of HUVECs which bind to the material
indicate that it is possible to control the initial cell
lOS
seeding density of a material. This control will be
important in materials which are used for co-culture. For
example, liver is a highly vascular material which contains
several different cell types among which are hepatocytes and
endothelial cells. Hepatocytes are immediately juxtaposed
to the endothelial cells. In this way, no cell is further
than two cells away from the bloodstream. There is ready
and rapid diffusion of metabolites to all cells. In order
to seed both cell types onto a matrix it will be necessary
to control the location and number of each type of cell to
be seeded. This need is addressed with materials such as
these, since we can control precisely the type and density
of cell binding domains.
Both control of the binding ligand and control of the
structural integrity were designed into the materials. The
elastin-based pentapeptide (VPGIG) was incorporated to
provide integral structural and elastomeric integrity.
Although complete characterization of the mechanical
properties has not yet been achieved, we have demonstrated
that the materials maintain an LCST, which is inherent to
polymers based on multiple repeats of (VPGIG) . Urry has
suggested that it is the 3-turn conformation adopted by the
proteins upon phase separation that provides the entropic
basis for the elastomeric properties of the proteins.®^
Thus, the observation of the LCST in our materials may
suggest retention of the 3-turn conformation in the protein
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rich phase of the biphasic system and favorable elastic
properties.
The surface stability studies show that the materials
are not insoluble in aqueous solution at 37 °C despite the
sub-ambient LCST. In order to produce an insoluble material
it may be necessary to crosslink the protein. Urry et al
.
have crosslinked similar proteins by Y-irradiation^\- this
is not ideal for cross linking these artificial extracellular
matrix proteins because the location of radical formation,
and hence of crosslinking, cannot be controlled. Other
available options are crosslinking by glutaraldehyde or
formaldehyde.^^ The absence of lysine residues preempts the
methods. Carbodiimide would cause crosslinking of the
glutamic and aspartic acid residues of the binding region
with amines. Thus it appears that the traditional
crosslinking methods are accordingly less than ideal.
A novel crosslinking option might come from the
incorporation of an unnatural alkyne derivative of
isoleucine. It has been shown in our laboratory that an
isoleucine derivative containing a terminal alkyne can be
incorporated into artificial proteins biosynthetically (vide
infra) . This alkyne derivative is apparently bound by the
isoleucyl tRNA synthetase and utilized to charge the
isoleucyl tRNA. Even low levels of isoleucine replacement
by the unatural alkyne derivative would allow sufficient
crosslinking of these residues through alkyne chemistry.
The crosslink density and the mechanical properties of the
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material could then be altered by varying the incorporation
of the alkyne derivative.
The incorporation of the alkyne would also allow for
crosslinking with other materials. The muscular arteries are
generally the arteries of interest for the design of small
diameter prostheses, for it is these arteries that fail and
are not readily repaired by current methods.^ As discussed
in chapter 1, the arteries are composed of three tunicas.
It will be possible to blend the elastin-like proteins with
collagen analogues to mimic both the tunica media and the
adventitia. Multilayered vascular grafts can be fabricated,
with crosslinking between and within the tunicas, to produce
vascular prostheses. The fabricated vascular grafts can
then be seeded with endothelial cells and smooth muscle
cells. These cells would be expected to remodel or rebuild
the extracellular matrix to produce a "natural" vessel.
An advantage of artificial extracellular matrix
proteins which have been designed through recombinant DNA
technology is that the proteins can be designed to contain
only specific signals. Fibronectin itself contains fibrin,
heparin, collagen, DNA, and cell binding domains.^'' It is
not beneficial to have all of these binding domains exposed
to the blood stream. Fibrin is involved in clotting and
thrombus formation. Readily available binding sites for
fibrin may promote the binding of fibrin followed by the
formation of thrombi. Recombinant DNA technology allows for
the isolation of function by the isolation of domains of a
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protein. As we have shown, it is possible to clone the CS5
region of fibronectin thus isolating only the ability to
bind to the a^Pi integrin receptor*
As demonstrated by the adhesion of recombinant
(CS5(VPGIG)2o)5 and (CS5(VPGIG)4o)3 to PTFE (see Appendix E)
,
these novel extracellular matrix materials can be used not
only as new graft materials, but to try to improve the
characteristics of currently available materials while new
materials are being developed. It is also important to note
that just as biology is not limited to incorporating one
signal into a molecule, we are not limited to one signal per
molecule. Through recombinant DNA techniques multiple
signals can be built into each molecule, whether they be
cell adhesion signals, molecular adhesion signals, or
protease degradation sites. Moreover, we are able to design
out these same signals and so devise materials for use where
the presence of any of these signals would be undesirable.
We can make materials that are less prone to degradation by
endoproteases. The current materials are the building
blocks for artificial extracellular matrices.
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APPENDIX A
GENETIC MAPS AND MANIPULATIONS
All DNA was synthesized on a 1 /xmol scale on a
Biosearch Model 8700 DNA synthesizer using phosphoramidite
chemistry/^ As described in chapter 3, all oligonucleotides
were purified, annealed and ligated into pUC18^% a cloning
vector which is depicted in Figure A.l, with the exception
of 28ap which was directly ligated into pET-28a (Figure
A. 2) and pEC2-link which was ligated directly into pEC2 . The
transfer vector, pEC2 (Figure A. 3) was used for inserting
(VPGIG)x into the Ban I site of the CSS and HBD regions and
for amplifying CS5(VPGIG)^ and HBD(VPGIG)y prior to ligation
into pET-28ap, the expression vector.
pET-28ap (Figure A. 4) was created by insertion of a new
cloning linker between the Nco I and Xho I sites in the
polycloning region in pET-28a. As seen in Figure A. 5, the
new cloning region consists of a start codon encoded in the
Nco I site, a cloning site encoding an Xho I restriction
site and two stop codons immediately following the cloning
site. This allows for the expression of the artificial
extracellular matrix proteins without long fusions which
would need to be removed after synthesis.
Figures A. 5, A. 6, A. 7, A. 8 and A. 9 show full
restriction maps of the DNA encoding 28ap, CS5, (VPGIG)5,
HBD, pEC2-link respectively as synthesized. pEC2-link was
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cloned directly into the Eco RI and Eag I sites of pEC2 and
sequenced. It was designed to allow cloning of (VPGIG)^
into the Ban I site and then transfer of the DNA into pET-
28ap for expression without long fusions.
DNA manipulations are described in more detail in
experimental sections pertaining to gene construction and
protein expression in Chapter 3 and Appendix B.
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BsmB I 51
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Pvu I 2066
Aua II 2059
BsrD I
Fspl
1935
1919
vAf'o 11 1837
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cloning sites
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POLYLINKER - ANTISENSE STRAND
Ban II Ava I
£cI136 11 Xma I Sse8387
1
Sac I Sma I Xba I Pst I Hind III
gaattCGAGCTCGGTACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGG
EcoR I Kpn I BamH I SaZ I Sph I
Apo I Acc65 I Hinc II
Acc I
BspM I
1
LacZ Ala Leu Ser Asn Ser Ser Pro Val Arg Pro Asp Glu Leu Thr Ser Arg Cys Ala His Leu Ser Pro Thr He Met Thr
Figure A.l The pUC18 cloning vector. The cloning vector is
shown with the DNA sequence of the polycloning region
depicted below the plasmid. Synthetic DNA was ligated
between the Bam HI and Eco RI site of the cloning region.
112
Bpu1102 1(80)
Dra 111(5127)
Xho 1(158)
Not 1(166)
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PVU 1(4426)
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^
Nru 1(4083)
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(5369 bp)
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Sap 1(3108)
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Apa 1(1334)
BSSH 11(1534)
EcoR V(1573)
Hpa 1(1629)
PshA 1(1968)
Bgl 1(2187)
Fsp 1(2205)
Psp5 11(2230)
Figure A. 2 pET-28a cloning vector, (reprinted with
permission from Novagen)
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POLYCLONING LINKER
Psll/ngl II Del I EcnR] D.ml DamI il Xb.il Snl I Engl Avrll II I'mI
5--CrGCAGATCT GATCA CAA ITC AIT ATG GGT GCC ATG GAT CCA TCT AGA CIC GAC GTC GGC CGT TAA CCV ACG ACA ICT GCAG-T
rsii
Figure A. 3 pEC2, a transfer vector. The transfer vector
designed by Eric Cantor is depicted with a blow up of the
polycloning region shown below the plasmid.
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Fiaure A 4 The expression vector pET-28ap as constructed
from pET-28a (reprinted with permission from Novagen .
The
expression vecto? with a blow up of the new do^^^ng
l^*^"^,
is shown. The new linker allows for cloning
into the Xho I
s!te wI?A subsequent expression of the
^^5°»binant protein
^Ith minimal amino acid fusions corresponding
to the start
site and the cloning site.
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Taq I
JJla TU
^liUl Xhng Taq I
Ai:a_L Hinr TT
II II III II
catgggcctcgagtaataag 26
ccggagctcattattcaqct
I I I I I I I
.||
J 9 21
} 9 21
\ 9 22
10
Figure A. 5 A full restriction map of 28ap. The restriction
map of 28ap as synthesized by solid state synthesis. The
Nco I and Sal I sites were used for cloning into the Nco I
and Xho I sites of pET-28a.
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ISau96 I
Nla IV
Sau96 I
Nla IV
EcoO109
B3pl2R6
Ban II
Apa I
Nla IV
Eco0109 I
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I I I
Taq I
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HinC II
Acc I
Sau3A
I
I
I
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Alw
Mbo II
HEtL_I BstY
II II
Sau3A I
Mbo I
I
Hae III
Gdi II
Dpn I EoiL
HinC II
Mbo II
Bbv TT
Sec I
ScrF I
Nci I
Map I
Hpa IT
Ben I
Xm I
2ma^
Sec I
ScrF I
Nci I
Ben I
Ava I
1
I I
I II I I I I I ...
AATTCGGGGCCCCTGTCGACGCTGAAGAGATCCAGATCGGCCACATCCCGCGTGAAG^^
GCCCCGGGGACAGCTGCCACTTCTCTACCTCTAGCCGGTGTAGGGCGCAOT
I I I
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7
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8
8
8
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9
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Banfl I
yho I Dpn I
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II I I I II
GGGGGTGCCGCTCGAGG
CCCCCACGGCGAGCTCCCTAG
I I
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91 98
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Figure A. 6 A full restriction map of CS5. The restriction
map of CSS as synthesized by solid state synthesis. The
ECO RI and Bam HI sites were used for cloning into pUC18.
The Ban I site was used for insertion of (VPGIG), multimers.
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Sau3A T
Mho T
Dpn I
Nia IV
ScrF I BstY T
Nci I SfaN I ScrF I SfaN I R=imH T
Msp I ScrF I Nci I ScrF I ScrF I Aiw I
Hpa II Nci I Msp I Nci I Nci I Msp I
Nia IV Msp I Hpa II Msp I Msp I Hpa II
nde T Ben I Hpa II Ben I Hpa II Hpa II Nia IV
EcqR T Ban I Ben I fisa_I SfaN I Ben I Ben I Ban I Alw Itill II III II I lilt
aaCtctaaggggtgecgggtatcggcgttcegggcatcggtgtaecgggcatcggtgttccgggcatcggtgttccgggtatcggggtgecg
.gatteeeeaeggeeeatagccgcaaggcccgtagccacatggcccgtagccacaaggcccgtagccacaaggcccatagccccacggcctag
I I • I I • M I • I I I •! I • I • I -I II
1 12 31 43 50 61 76 87 94
6 16 31 46 61 76 87
12 31 46 61 76 91
16 31 46 61 76 91
16 31 46 61 76 93
16 35 46 65 93
16 93
93
94
94
94
Figure A. 7 A full restriction map of .(VPGIG)5. ^he
restriction map of (VPGIG), as synthesized by solid state
synthesis is shown. The Eco RI and Bam HI sites were
used
for cloning into pUC18.
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Fnu4H I
£aa_j: Sriu-iA T
Not T Mbo T
Fnu4H I Nla IV
BstU I BstY I
Sec I R^mH T
Sac TT Alw I
Taq I Msp T NspB TT Taq I
Sal I Hpd II nsO-I Xho T Dpn T
HlnC II R5fl I Hqa I Fnu4H I P^pR7 T
Ace T Map TT BstU I Taq I Nla IV Hap TTT Mnl T
F-COR T H:^P TTT Fnu4H I BstB_-I Ran T F.aP T Avr^ T Aiw !
I I I II I I I I I II I I I M I I I I I I M
.AATTCGTCGACCGrrACGTTGTACTGCCGCGTCCGGTTTGCTTCGAAAAAGGTAT
GCAGCTGGCAATGCAACATGACGGCGCAGGCCAAACGAAGCTITrTCCAT
I II • I 1 • I III I • II • • • I I I I I I I I I I I I t •
1 14 27 43 75 82 90 97
7 17 29 44 75 83 93
7 22 30 78 90
7 34 79 90 97
8 34 79 91
79 96
79 96
80 96
81 96
81 97
82 97
82
84
Figure A. 8 The restriction map of HBD as synthesized by
solid state synthesis. The Eco RI and Bam HI sites were
used for cloning into pUC18. The Ban I site was used for
insertion of (VPGIG);, multimers.
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Nlfi TTT
Sty T
Spp T
s-^"^ft T
Wbo T
HlaC_LI J2sa_L Fnu4H I Fnu4H I
EcnR IV Taq I££QB-L Alw I ^ Ha.^ TTT
42
Figure A. 9 The restriction map of pEC2-link as synthesized
by solid state synthesis. The Eco RI and Sal I sites were
used for cloning into pEC2 . The Ban I site was used for
insertion of (VPGIG), multimers. j_
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APPENDIX B
(HBD(VPGIG)2o)4 DESIGN AND SYNTHESIS
B.l Introduction
Extracellular matrix proteins contain multiple signals
which are encoded in the primary and possibly secondary and
tertiary structures of the molecule. Fibronectin contains
several integrin binding domains, "'"^'^""^^ as well as heparin
and collagen binding domains. ^"'^^ Laminin, a second
extracellular matrix protein, also contains integrin and
heparin binding domains. ^^'^^ Furcht and colleagues have
found a peptide sequence in porcine laminin
(RYWLPRPVCFEKGMNYTVR) which binds heparan sulfate.
Cells have heparin sulfate proteoglycans on their
surfaces that can bind to the heparin binding domain (HBD)
.
It has been demonstrated that a combination of cell binding
domains and HBD induces focal adhesion contact formation, a
more permanent anchoring where the cytoskeleton fibrils
appear to be connected through cell membrane receptors to
the extracellular matrix, in f ibroblasts^°°.
The inclusion of the heparin binding domain may aid in
the formation of more permanent adhesions to the artificial
extracellular matrix materials. In addition, it has been
shown that heparin inhibits the proliferation of smooth
muscle cells. It will be possible to bind heparin to the
artificial extracellular matrix proteins that include
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heparin binding domains to inhibit the proliferation of
smooth muscle cells.
B.2 Experimental Methods
B.2.1 Preparation of Synthetic DNA
Oligonucleotides (Figure A. 8) were synthesized on a 1
Hmol scale on a Biosearch Model 8700 DNA synthesizer using
phosphoramidite chemistry^®. Crude oligonucleotides were
purified by denaturing polyacrylamide gel electrophoresis
and eluted using the "crush and soak" method^\ Purified
oligonucleotides were annealed at 80 °C and allowed to cool
to room temperature over several hours. The annealed HBD
duplex (Figure A. 8) was phosphorylated with T4
polynucleotide kinase, ethanol precipitated and dried in
vacuo .
B.2. 2 Cloning and Amplification of Synthetic DNA
Purified HBD was ligated into Eco RI/Bam HI digested
pUC18 and used to transform E. coli strain DH5aF'. Cells
were grown at 37 °C overnight on 2xYT solid medium
containing 200 /iig/ml ampicillin, 25 /xg/ml 3-
isopropylthiogalactoside (IPTG) and 4 0 /xg/ml of the
chromogenic substrate 5-bromo-4-chloro-3-indolyl-3-D-
galactopyranoside (X-Gal) for blue-white screening. Plasmid
DNA from white transformants was sequenced using Sequenase
2.0 (Amersham Life Sciences) to verify the identity of the
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insert. After isolation of the recombinant plasmid from a
15 ml 2XYT culture the HBD DNA was digested with Eco RI/Bam
HI and the fragments were separated by nondenaturing
polyacrylamide gel electrophoresis. The DNA monomer was
eluted from the polyacrylamide slice using the "crush and
soak" method".
B.2.3 Cloning of HBD in Transfer Vector
Purified HBD monomer was ligated into Bam HI/ Eco RI
digested pEC2 plasmid DNA (the resultant plasmid was
designated pEC2-HBD) , and used to transform E. coli strain
DH5aF'. Cells were grown overnight on 2xYT solid medium
containing 34 /xg/ml kanamycin. Plasmid DNA from single
colonies was verified for HBD insert by Bam HI/Eco RI
digestion followed by 1 % agarose gel electrophoresis and
staining with ethidiumbromide (EtBr) ; bands of 101 bp
indicate proper ligation.
B.2.4 Polymerization of the (VPGIG)5 Monomer and Cloning of
(VPGIG)5 Multimers
Purified monomeric (VPGIG)5 DNA was self-ligated with
T4 DNA ligase to form a population of multimers. Multimers
were ligated into Ban I digested, dephosphorylated pEC2-HBD.
The recombinant plasmids were used to transform E. coli
strain DHSaF'. Transformants were screened by PCR^^ with
cycling times and temperatures as follows: 96 °C, 1 min; 45
°C, 2 min; 72°C, 2 min with 35 cycles. Vent polymerase was
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used with Pst I site primers for pBR322 (New England
Biolabs)
.
Amplified DNA was visualized with EtBr following
separation by 1% agarose gel electrophoresis. A clone
encoding 4 repeats of the (VPGIG)5 monomer was chosen. The
recombinant plasmid was designated pEC2-HBD (VPGIG) 20.
B.2.5 Construction of Bacterial Expression Vector
Recombinant pEC2-HBD (VPGIG) 20 was digested with Xho
I /Sal I to release the HBD- (VPGIG) 20 DNA cassette. The
cassette was separated by 1% agarose gel electrophoresis and
recovered by extraction with Qiaex II DNA extraction kit
(Qiagen) . The recovered DNA was ligated into Xho I
digested, dephosphorylated pET-28ap (the resulting plasmid
was designated pET-28ap (HBD (VPGIG) 20) x where x designates the
number of cassettes which have been ligated) , and used to
transform E, coli strain DH5aF'. Transformants were
screened for the presence and orientation of each multimer
by Pflm I/Xho I digestion. This process was performed
repeatedly (Figure B.l) to obtain a recombinant plasmid,
designated pET-28ap (HBD (VPGIG) 20) 4 / which was used to
transform the expression host, E. coli strain
BL21 (DE3)pLysS.
B.2.6 Protein Expression, Batch Phase, Rich Medium
Single colonies of BL21 (DE3 ) pLysS containing
recombinant pET-28ap (HBD (VPGIG) 20) 4 were used to inoculate 5
ml of 2xYT medium containing chloramphenicol (34 ^iq/ml) and
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kanamycin (34 ^g/ml)
.
The cultures were grown to saturation
and a 50 nl aliquot was used to inoculate fresh 5 ml volumes
of 2xYT medium containing chloramphenicol (34 /xg/ml) and
kanamycin (34 /ig/ml) . The cultures were grown to OD.no = 1
at 37 °C and protein expression was induced by the addition
of IPTG to a final concentration of 1.0 mM. Samples were
taken at t = 0, 1, 2 hr, centrifuged at 14,000 x g and
resuspended in distilled H^O at a concentration of 0.2 ODgoo
units per 10 /liI for analysis by SDS-PAGE.
B.3 Results and Discussion
Samples were loaded onto a 10% polyacrylamide gel and
separated by electrophoresis under denaturing conditions.
Protein bands were stained with Coomassie Brilliant Blue R-
250. Figure B.2 is a 10% polyacrylamide gel containing
whole cell lysate samples of BL21 (DE3 ) pLysS pET-28ap-
(HBD (VPGIG) po) ^ • Lane 1 contains molecular weight standards
while lanes 2-4 contain whole cell lysates from cultures of
colony latt=0, t=lhr, t=2hr respectively. Lanes
5-7, 8-10, and 11-14 contain whole cell lysate from colonies
2-4 respectively. In no case can a band be seen which
corresponds to recombinant protein (expected molecular
weight near 46 Kda) .
The lack of protein expression may be attributed to the
choice of codon usage at the start of the recombinant DNA.
The (CSS (VPGIG) 2o) 5 construct is very similar to the
(HBD(VPGIG)2o) 4 construct. The differences are limited to
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the cell binding domains. Since the encoded DNA and mRNA
messages begin with the binding domains it is likely that
the expression problem lies within HBD. This must be
confirmed by sequencing the synthetic gene in the expression
vector to be sure that no base pair deletions or additions
have occurred during genetic manipulations which may cause
lack of expression. If no genetic defects exist copolymers
of (CS5(VPGIG)^HBD(VPGIG)y) can be constructed. In this
case the CSS domain will be at the start of the gene and may
thus allow expression of the HBD.
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Figure B.l A schematic of the insertion of HBD(VPGIG)2o
cassettes into pET-28ap.
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8 9 10 11 12 13
Figure B.2 A 10% SDS-PAGE of an (HBD (VPGIG) 20) 4 expression
Lane 1 contains molecular weight standards while lanes
2-4
contain whole cell lysates from cultures of colony 1 at t
0 t=lhr,t=2hr respectively. Lanes 5-7, 8-10, and
11-13 contain whole cell lysates from colonies 2-4
respectively at similar time points.
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APPENDIX C
DESIGN AND SYNTHESIS OF (VPGIG)x
C.l Experimental Methods
C.1.1 Preparation of Synthetic DNA
Oligonucleotides were synthesized on a 1 /Ltmol scale on
a Biosearch Model 8700 DNA synthesizer using phosphoramidite
chemistry/® Oligonucleotides were annealed at 80 °C and
allowed to cool to room temperature over several hours. The
annealed pEC2-link duplex (Figure A. 9) was phosphorylated
with T4 polynucleotide kinase, ethanol precipitated and
dried in vacuo.
C.1.2 Cloning and Amplification of Synthetic DNA
The pEC2-link duplex was ligated into Eco RI/Eag I
digested pEC2 and used to transform E. coli strain DH5aF'.
Cells were grown at 37 °C overnight on 2xYT solid medium
containing 25 /ng/ml kanamycin. Plasmid DNA from
transformants was sequenced using Sequenase 2.0 (Amersham
Life Sciences) to verify the identity of the insert.
C.1.3 Cloning and Amplification of (VPGIG)5
Purified (VPGIG) 5 DNA was ligated into Eco RI/Bam HI
digested pUC18 and used to transform E. coli strain DH5aF'.
Cells were grown at 37 °C overnight on 2xYT solid medium and
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sequenced as described in chapter 3. After isolation of the
recombinant plasmid from a 1 liter 2xYT culture, the
(VPGIG)^ DNA was digested with Ban I and the fragments were
separated by nondenaturing polyacrylamide gel
electrophoresis. DNA monomer was eluted from the
polyacrylamide slice, using the "crush and soak" method/^
C.1.4 Polymerization of the (VPGIG),, Monomer and Cloning of
(VPGIG)s Multimers
Purified monomeric (VPGIG) r, DNA was self-ligated with
T4 DNA ligase to form a population of multimers. Multimers
were ligated into Ban I digested, dephosphorylated pEC2-
link. The recombinant plasmids were used to transform
E. coli strain DH5aF'. Transformants were screened by PGR
with cycling times and temperatures as follows: 96 "C, 1
min; 45 °C, 2 min; 72°C, 2 min with 35 cycles. Vent
polymerase was used with Pst I site primers for pBR322 (New
England Biolabs) . Amplified DNA was visualized with EtBr
following separation by 1% agarose gel electrophoresis. A
clone encoding 11 repeats of the (VPGIG) 5 monomer was
chosen. The recombinant plasmid was designated pEC2-link-
(VPGIG) 5,.
C.1.5 Construction of Bacterial Expression Vector
Recombinant pEC2-link- (VPGIG) 55 was digested with Xho
I/Sal I to release (VPGIG) 55. The DNA was separated by 1%
agarose gel electrophoresis and recovered by extraction with
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Qiaex II DNA extraction kit (Qiagen)
. The recovered DNA was
ligated into Xho I digested, dephosphorylated pET-28ap and
used to transform E. coli strain DH5aF'; the recombinant
plasmid was designated pET-28ap (VPGIG) 55. Transformants
were screened for the presence and orientation of each
multimer by Pflm I/Xho I digestion. DNA ligated in the
correct orientation was indicated by a DNA band of -12 50 bp
as visualized by 1 % agarose gel electrophoresis followed by
staining with ethidiumbromide. The expression host
BL21 (DE3) pLysS was transformed with pET-28ap (VPGIG) 55.
C.1.6 Protein Expression, Batch Phase, Rich Medium
Single colonies of BL21 (DE3 ) pLysS containing
recombinant pET-28ap (VPGIG) 55 were used to inoculate 5 ml of
2xYT medium containing chloramphenicol (34 jtig/ml) and
kanamycin (34 /iig/ml) . The cultures were grown to saturation
and 50 ill was used to inoculate fresh 5 ml volumes of 2xYT
medium containing chloramphenicol (34 /xg/ml) and kanamycin
(34 /xg/ml) . The cultures were grown to ODgoo = 1 at 37 °C
and protein expression was induced by the addition of IPTG
to a final concentration of 1.0 mM. Every 60 minutes for
2 hrs 1 ml samples were taken, centrifuged at 14,000 x g and
resuspended in distilled H2O at a concentration of 0.2 ODgoo
units per 10 jul for analysis by SDS-PAGE. However, SDS-PAGE
of whole cell lysate followed by staining with Coomassie
Briliant blue revealed no bands at 24,483 Da, the expected
molecular weight.
C.1.7 Protein Expression, ^H-Glycine, M9AA
A single colony of BL21 (DE3) pLysS containing
recombinant pET-28ap (VPGIG) 55 was used to inoculate 5 ml of
M9AA containing chloramphenicol (34 ^iq /ml) and kanamycin
(34 /ig/xnl) . The culture was grown to saturation and used to
inoculate 25 ml of M9AA medium containing chloramphenicol
(34 /xg/ml) and kanamycin (34 ^q/ml) . The culture was grown
to ODgoo = 0.8 at 37 °C and protein expression was induced by
addition of IPTG to a final concentration of 1.0 mM; after
allowing T7 RNA polymerase to be produced, 34 ^,q/ml
rifampicin was added to inhibit E. coli RNA polymerase; 10
minutes later 150 /Ltl of 1 /iCi//il glycine was added for
incorporation into the artificial protein. Every 60 minutes
for 2 hrs 1 ml samples were taken, centrifuged at 14,000 x g
and resuspended in distilled H2O at a concentration of 0.2
ODeoo units per 10 ill for analysis by 10 % SDS-PAGE.
Following SDS-PAGE, run at 16 mA through the stacking gel
and 30 mA through the resolving gel, the gel was stained
with Coomassie Brilliant Blue R-250, dried in vacuo and Xray
film was exposed to the gel for 2 days. The developed film
showed a dark band appearing at 2 3 Kd in the induced samples
(data not shown) . Still no band could be seen on the
Coomassie stained radioactive gel indicating that the
recombinant protein does not stain with Coomassie Blue. The
lack of staining of the gel makes it difficult to determine
the amount of expression prior to purification of the
recombinant protein.
APPENDIX D
SEM ANALYSIS OF PROTEIN COATING
Protein coatings were prepared as described in chapter
3. Briefly, 40 fil of 40 mg/ml solutions of protein were
spread on 12 mm glass coverslips. The protein coated
coverslips were then dried in vacuo at 55 °C. Coverslips
were imaged at this stage after coating with gold palladium.
Protein coated coverslips were incubated at 37 °C with
0.5 ml water to remove excess protein. They were once again
dried at 55 °C in vacuo. Coverslips were also imaged at
this stage.
Imaging and elemental analysis were both performed on a
JEOL 6320-FXI field emission microscope. The samples were
coated with gold/palladium by sputter coating, then imaged
at 10 kV. Samples for elemental analysis were analyzed
uncoated at 5 kV.
Figures D.la & b show x-ray elemental analysis of the
glass coverslip (Fig. D.la) and glass coated with
(CSS (VPGIG) 20)5 (Fig. D.lb) prior to removal of excess
protein. A silicon peak is apparent on the uncoated
coverslip, but it is not seen on the protein coated
coverslip prior to soaking in PBS to remove excess protein.
On the protein coated coverslip profile there is also marked
suppression of the oxygen peak and loss of the sodium peak
while a carbon peak can clearly be seen. The protein
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coating was thick enough that detection of the underlying
glass was not possible. Once excess protein was removed,
the glass signals were visible even with the protein
coating, so this method could not be used to determine
protein coatings. Determination of coating was then done by
scintillation counting as described in chapter 4.
Figures D.2a & b show SEM images obtained from
(CS5 (VPGIG) 20) 5 coated coverslips before excess protein was
removed (Fig D.2a) and after protein removal (Fig D.2b). In
both cases the surface looks cracked and textured. Glass
alone looks quite smooth with no cracks (data not shown)
.
These images coupled with the scintillation counting data
suggest complete coverage of the coverslips prior to cell
culturing.
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Figure D.l Elemental analysis of P^^^ein
coated glass
co?erslips. A4 . la is a glass coverslip with
prominent Si and Na peaks can seen and no
C peak is seen
Ka i= nlass coverslip coated with (CS5 (VPGIG) 20} b/
Si'and Na plakrhavrbeen'lost and a C peak
can clearly be
seen.
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a.
Figure D.2 SEM images of (CSS (VPGIG) 20) 5 coated coverslips.
A4.2a shows a protein coated coverslip prior to removal of
excess protein, while A4.2b shows a protein coated coverslip
after removal of excess protein. Both samples are coated
with gold/palladium and imaged at 5 kV.
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APPENDIX E
HUVEC CULTURING ON PTFE COATED COVERSLIPS WITH ARTIFICIAL
EXTRACELLULAR MATRIX PROTEIN COATINGS
E.l Materials and Methods
E.1.1 PTFE Coating of Coverslips
Glass coverslips were coated with a thin layer of
p^pj, 102 Briefly, a hot plate was heated to 300 °C; a 12 mm
glass coverslip was placed on the hot plate and a piece of
PTFE was manually drawn across the coverslip 4 times in the
same direction. PTFE coating was verified by SEM imaging of
gold/palladium coated coverslips. Figure E.l shows an SEM
image; the PTFE is seen in the image as long peaks and
valleys
.
E.l. 2 Protein Coating of Coverslips
Coverslips were placed into the wells of a 24 well
culture dish and 0.5 ml of a 40 mg/ml protein solution was
added. After incubation at 4 °C overnight, the protein
solution was removed and the coverslips were dried at 55 °C
in vacuo as described in chapter 3.
E.l. 3 Determination of Protein Stability
The determination of the stability of the protein on
the surface was done using ^H-glycine labeled protein
137
coupled with scintillation counting as described in chapter
4. The stability was determined only by the method in which
0.5 ml of PBS was added to each well for 3 hours during
which time small aliquots were taken at 30 minute intervals
to determine the amount of protein solubilized over time.
The amount of protein remaining on the coverslips was also
determined by scintillation counting as described in chapter
4 .
E.1.4 HUVEC Culturing
Cell culturing was done as described in chapter 3.
Coverslips coated with PTFE , as well sls PTFE adsorbed, with
(CSS (VPGIG) 2o) 5 and (CS5 (VPGIG) 40) 3 from solutions of protein
in formamide and water, and as suspensions of protein in
trifluoroethanol (TFE) were used for cell culturing. HUVECs
were suspended in serum free M199 at 10'' cells/ml and 1 ml
of suspension was added to each well. HUVECs were incubated
at 37 °C and 5% CO: fo^ 4 hours.
E.2 Results and Discussion
Table E.l shows the amount of protein removed after 3
hr incubation in PBS at 37 °C as well as the amount of
protein remaining on the PTFE coated coverslips after the
incubation period. Approximately 1 of each protein
remains on the surface with the exception of (CS5 (VPGIG) 20) 5
adsorbed from formamide, where more than 2 /xg of protein
remained. This correlates to a protein thickness of ^20 A.
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Only moderate improvement of cell adhesion was seen on
the protein coated PTFE surfaces as compared to the PTFE
surfaces alone.
A slight increase in the number of cells adhered to
artificial extracellular matrix treated coverslips was
observed by visualization by phase contrast microscopy.
Quantitative evaluation must be done to determine the
significance of the increase in cell adhesion.
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Table E.l Stability of Protein Coatings on
PTFE Coated Glass
Casting (CS5 (VPGIG) 20) % (CS5 (VPGIG) 40) 3
Solvent
Removed Remaining Removed Remaining
Formamide 11.4 ±3.2 2.4 ±0.3 14.0 ±2.9 1.0 ±0.1
Water 12.6 ±4.2 1.4 ±0.1 15.0 ±1.9 1.5 ±0.1
TFE 19.0 ±1.9 0.7 ±0.1 11.0 ±2.3 0.8 ±0.1
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Figure E.l SEM image of PTFE spread on glass. The PTFE
coated coverslip was coated with gold/palladium and imaged
at 5 kV. The streaked appearance of the surface is due to
the PTFE.
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APPENDIX F
2-D NOSY NMR SPECTRUM of POLY (AG)
To determine whether there had been mutation in (AG) 240
a 2-D NOSY NMR spectrum was taken at 500 MHz. Figure F.l
shows the spectrum obtained. Cross peaks can clearly be
seen between putative valine methyl resonance at 1.1 ppm and
the Gly C„ peak at 4.3 ppm as well as between the 1.1 ppm
peak and the Ala Cp. This information coupled with the
amino acid analysis data reported in chapter 2 indicate that
there is valine present in the backbone of (AG) 240-
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